STATE PHARMACEUTICALS CORPORATION OF SRI ......2020/04/15 · Specification Diclofenac Sodium suppository 25mg Each suppository to contain 25mg of Diclofenac Sodium BP/USP in a suitable

TENDER NO LP/MSD/CPU-DHS/SPECIAL/URGENT/001/2020CLOSING DATE 15/04/2020

CLOSING TIME 02.00 PM (14.00 HRS)

DELIVERY REQUIRED IMMEDIATELY UPON RECEIPT OF A PURCHASE ORDER; WITH LOCALY AVAILABLE STOCKS (EX STOCKS)

NO OF ITEMS 418

CONDITIONS APPLICABLE FOR THE TENDER AND CONDITIONS OF SUPPLY; ARE INDICATED AT THE END OF THE SCHEDULE

ITEM

1 SR No 00105102

Item Clofazimine Tablet 100mg 39,825 Tabs

Specification Clofazimine Tablet 100mg

Each tablet to contain 100mg of Clofazimine.

Note:

01.The shelf life of the product should be minimum of 24 months.

2 SR No 00303501

Item Sumatriptan Tab. 50mg 2,400 Tabs

Specification Sumatriptan Tablet 50mg

Each tablet to contain 50mg of Sumatriptan Succinate BP.

Note:


3 SR No 00303702

Item Phenytoin sodium Tab. 50mg 388,476 Tabs

Specification Phenytoin sodium tablets BP/USP 50mg

Each coated tablets to contain 50mg of Phenytoin sodium BP/USP

Note:


4 SR No 00402801

Item Pyridoxine Tab. 10mg 140,043 Tabs

Specification Pyridoxine Tablets BP 10mg.

Each tablet to contain 10mg of Pyridoxine Hydrochloride BP

Tablet should also conform to dissolution test for Pyridoxine

Hydrochloride tablet as per USP.

OR

Pyridoxine Hydrochloride Tablets USP 10mg.

Each tablet to contain 10mg of Pyridoxine Hydrochloride USP

Note:

01.Sufficient overage to be added to ensure the the adequate shelf

life

02.The shelf life of the product should be minimum of 24 months

5 SR No 00500301

Item Fluticasone MDI ,125mcg/dose120d 1,992 Inhals

QUANTITY

URGENT (SPECIAL) TENDER

[FOR STATE HEALTH SECTOR]

The Central Purchasing Unit – DHS (CPU-DHS) of the State Pharmaceuticals Corporation of Sri Lanka invites quotations (Bids)

from the Local Agents of the manufacturers who have obtained NMRA registration for the products; for supply of the below

mentioned items.

STATE PHARMACEUTICALS CORPORATION OF SRI LANKA

Page No 1 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Fluticasone propionate 125mcg / metered dose,120 dose unit

Each pressurized container equipped with metering valve and

suitable propellents

to contain suspension of fluticasone propionate to deliver 125mcg of

fluticosone

propionate per metered inhalation.

Note:

1. Each non-reactive areosol container equipped with metered dose

valve,to be

filled with 120 doses.

2. Tenderers should give detail specifications of the product offered

along

with sample.6 SR No 00903201

Item Nepafenac ophthalmic susp.0.1%,3ml vial 18,711 Vials

Specification Nepafenac ophthalmic suspension 0.1% w/v ,3ml

Each 3 ml dropper bottle to contain 0.1% w/v Nepafenac for

ophthalmic use

Note:

1.The tamper - evident container (dropper bottle) should

assure the sterility of the product.

2.Product should be stable for minimum of 24 months when

stored at a temperature range of 28'C-32'C

3.Each bottle should be labelled accordingly.7 SR No 01000401

Item Clotrimazole 1%+Lignocaine 2%Ear drops 10ml vial 4,632 Vials

Specification Clotrimazole 1% w/v with 2% w/v Lignocaine Ear drops

Each 10ml Dropper bottle to contain sterile solution of Clotrimazole

BP/USP 1%

w/v with 2% w/v Lidocaine BP/USP.

Note:

1.The tamper evident dropper bottle should assure the

sterility of the product.

2.Each bottle should be packed in light-resistant

boxes.

3.Product should be stable for a minimum of 02 years

when stored at a temperature range of 28'C-32'C.


Item Procarbazine capsule 50mg 369 Caps

Specification Procarbazine Hydrochloride capsules USP 50mg

Each capsule to contain Procarbazine Hydrochloride USP equivalent

to 50mg of

Procarbazine

Note:


9 SR No 01204801

Item Docetaxel injection 20mg vial 2,934 Vials

Specification Docetaxel Injection 20mg Vial

Each 0.5ml, sterile solution to contain 20mg of Docetaxel for

intravenous

infusion

Note:

1.This injection should be stable for a minimum of 24 months when

stored under

manufacturer's conditions.

2.Each vial should be labeled accordingly.10 SR No 01205002

Page No 2 of 89




NO OF ITEMS 418


ITEM QUANTITY

Item Irinotecan injection 100mg/5ml 2,196 Vials

Specification Irinotecan hydrochloride trihydrate Injection 100mg in 5ml Vial

Each 5ml vial to contain Irinotecan hydrochloride trihydrate

equivalant to 100mg

of Irinotecan hydrochloride for intravenous use.

Note:

1. The injection should be stable for a minimum of

24 months when stored at a temperature range of 28'C-32'C

2. Each vial should be labelled accordingly.11 SR No 01400304

Item Diclofenac sodium Supp. 25mg 28,350 Supps

Specification Diclofenac Sodium suppository 25mg

Each suppository to contain 25mg of Diclofenac Sodium BP/USP in a

suitable

suppository base.

Note:

1. This suppository should be stable for a minimum of 24 months

when stored

at a temperature range of 28'C-32'C.

2. Each suppository should be labelled accordingly12 SR No 01600301

Item Fuller's earth ,60g bottle 177 Bots

Specification Fuller's earth (As fine powder)

Pack; 60g to be packed in a container

13 SR No 01600401

Item Methionine tablet 500mg 17,172 Tabs

Specification Racemethionine tablets USP 500mg

Each tablet to contain 500mg of Racemethionine USP

Note:


14 SR No 01301502

Item Tamsulosin capsule 0.4 mg 1,707,816 Caps

Specification Tamsulosin capsule BP 0.4 mg

Each capsule to contain 400 mcg of Tamsulosin as hydrochloride

Note:


15 SR No 00701804

Item Methylprednisolone IV Inj.500mg 12,825 Vials

Specification Methylprednisolone Sodium Succinate for Injection USP, 500mg

Each vial to contain Methylprednisolone Sodium Succinate

equivalent to 500mg of

Methylprednisolone USP for intramuscular, slow intravenous

injection or

Intravenous infusion. To be supplied with suitable diluent.

Note:

1.This injection should be stable for a minimum of 24

months when stored at a temperature range of 28'C-32'C.


Item Finasteride tablet 5mg 112,179 Tabs

Specification Finasteride tablets 5mg

Each tablet to contain 5mg of Finasteride BP/USP/IP

Note:


Page No 3 of 89




NO OF ITEMS 418


ITEM QUANTITY

17 SR No 00305001

Item Co-careldopa Tab. 25/100mg 339,099 Tabs

Specification Co-careldopa tablets BP 25/100mg

Each tablet to contain 100mg of Levodopa BP, and carbidopa BP

equivalent to 25mg

of Anhydrous Carbidopa

OR

Carbidopa and Levodopa tablets USP 25/100mg

Each tablet to contain 100mg of Levodopa USP and Carbidopa USP

equivalent to

25mg of Anhydrous Carbidopa.

Note:


18 SR No 00203203

Item Isosorbide Mononitrate SRtablet 30mg 13,563,399 Tabs

Specification Isosorbide mononitrate SR (prolonged- release) tablet 30mg

Each prolonged-release coated tablet to contain 30mg of Isosorbide

mononitrate BP.

Note:


19 SR No 00202101

Item Bosentan Tab. 125mg 123,912 Tabs

Specification Bosentan tablet 125mg

Each Tablet to contain 125mg of Bosentan

Note:


20 SR No 00501601

Item Beractant 8ml (25mg/ml) vial 1,266 Vials

Specification Beractant suspension 8ml vial

Each 8ml vial to contain Beractant suspension providing Phospholipid

25mg/ml with lipids

and proteins to be administered by endotracheal tube or other

suitable device.

Note:

01.Shelf life of the product should be minimum of 24 months21 SR No 00304002

Item Sodium valproate Tab. 200mg 23,219,850 Tabs

Specification Sodium Valproate Tablet BP, 200mg.

Each tablet to contain 200mg of Sodium Valproate BP.

OR

Sodium Valproate enteric - coated tablets BP 200mg.

Each enteric coated tablet to contain 200mg of Sodium Valproate BP.

Note:

1.This tablet should be stable for a minimum of 24 months when


2.Tablets should be packed in moisture proof strip pack

22 SR No 00902001

Item Balanced salt, Solu. 500mlplastic bottle 16,770 Vials

Page No 4 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Balanced salt solution for irrigation of eye.

Each 500ml plastic bottle to contain sterile solution of 0.64% of

Sodium Chloride 0.39%

of Sodium Acetate 0.17% of Sodium Citrate, 0.048% of Calcium

Chloride 0.03% of

Magnesium Chloride and 0.075% of Potassium Chloride in a suitable

base for

irrigation of eye.

Note :

01. Each bottle to be labelled accordingly.


23 SR No 01103801

Item Chlorhexidine solution20%v/v,500ml bot 6,579 Bots

Specification Chlorhexidine Gluconate Solution BP/USP 20% v/v

Each 500ml container to contain 20% v/v of Chlorhexidine Gluconate

solution BP/USP equivalent to Chlorhexidine Gluconate

Solution 4% w/v with a suitable colorant.

Note:

1. Solution should be preserved in airtight, sealed containers with a

screw cap.

2. This product should be stable for a minimum of 24 months when

stored at a temperature range of 28¿C- 32¿C.

3. Each bottle should be clearly labeled accordingly with the

indications for use, strength of the solution and

necessary instructions for use. Label should have letters of readable

size.

4. There should be a leaflet with each container giving relevant

information such as chemical composition, instructions

for use etc.

5. Should have a valid registration from NMRA.

6. The supplier should provide a certificate endorsing good

manufacturing practice at the production facility ( GMP

certification).

24 SR No 01101101

Item Calamine Powder 349,209 gs

Specification Calamine BP/USP (As fine powder)

Pack: 500g in a well closed container

Note:


25 SR No 00401903

Item Magnesium sulphate inj. 50%in 10ml 40,920 Amps

Specification Magnesium sulphate injection BP/USP 50%.

Each 10ml ampoule to contain 50% w/v of Magnesium Sulphate BP

or USP in water for injection BP/USP for intramuscular,

slow intravenous injection or intravenous infusion.

Note:

1. This injection should be stable for a minimum of 24 months when

stored at a temperature range of 28'C-32'C.

2. Each ampoule should be labelled accordingly.

26 SR No 01400901

Item Leflunomide tablet 10 mg 757,614 Tabs

Page No 5 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Leflunomide 10 mg

Each coated tablet to contain 10mg of Leflunomide

Note:


27 SR No 00902101

Item Fluorescein sodium Inj.10%,5ml vial 1,335 Vials

Specification Fluorescein Injection BP/USP,10%w/v

Each 5ml vial to contain Fluorescein sodium BP/USP 10%, in water for

injection

BP/USP for intravenous use as diagnostic fluorescein angiography or

angioscopy

of fundus and iris.

Note;

1.This injection should stable for a minimum of 24


2.Each vial should be labelled accordingly28 SR No 01300602

Item Potassium citrate tablet1080mg 150,051 Tabs

Specification Potassium citrate extended-release tablet USP 1080mg

Each tablet to contain 1080mg (10mEq) of potassium citrate USP

Note:


02. The product should be preserve in tight containers.

29 SR No 00406202

Item Calcium polystyrene sulphonate15g-17g powder sachet 22,530 Sachets

Specification Calcium polystyrene sulphonate 15g-17g powder sachet

Each 15g-17g sachet to contain calcium polystyrene sulphonate and

each 1 g powder to contain 0.975 g - 1g of calcium

polystyrene sulphonate for oral or rectal administration after

reconstitution.

Note:

The shelf life of the product should be minimum of 24 months

30 SR No 00303701

Item Phenytoin sodium Tab. 25mg 101,904 Tabs

Specification Phenytoin Tablets BP/USP 25mg

Each coated tablets to contain 25mg of Phenytoin Sodium BP/USP

Note:


31 SR No 00306701

Item Quetiapine tablet 25mg 373,650 Tabs

Specification Quetiapine tablets 25mg

Each tablet to contain 25mg of Quetiapine

Note :


32 SR No 01206701

Item Anastrozole tablet 1mg 343,401 Tabs

Specification Anastrozole Tablet 1mg

Each Tablet to contain 1mg of Anastrosole

Note:


Page No 6 of 89




NO OF ITEMS 418


ITEM QUANTITY

33 SR No 00304202

Item Clobazam Tab.10mg 1,682,412 Tabs

Specification Clobazam tablet 10mg

Each tablet to contain 10 mg of Clobazam BP

Note:


34 SR No 01400201

Item Ibuprofen tablet 200mg 11,033,376 Tabs

Specification Ibuprofen tablets BP 200mg

Each tablet to contain 200mg of Ibuprofen BP. Tablet should also

conform to

dissolution test for Ibuprofen as per USP

OR

Ibuprofen tablets USP 200mg

Each tablet to contain 200mg of Ibuprofen USP.

Note:


35 SR No 01204904

Item Paclitaxel injection260mg 4,887 Vials

Specification Paclitaxel Injection USP, 260mg

Each vial to contain 6mg/1 ml of sterile, stabilized solution of

paclitaxel USP, suitable for dilution for intravenous

administration.

Note:

1.This product should be stable for a minimum of 24 months when

stored at a temperature below 25?C

2.Each vial should be labelled accordingly.

3.One set of administration device and suitable diluent compatible

with Paclitaxel injection,to be supplied with each

vial of Paclitaxel injection.

Administration device sets should be

3.1.Free from Polyvinyl Chloride (PVC) and di-(2-ethylhexyl) Phthalate

(DEHP)

3.2.Contain needle, in line filter with a microspores membrane not

greater than 0.22 micrometer and a poly

ethylene- lined.36 SR No 01206301

Item Lenalidomide capsule 5mg 14,715 Caps

Specification Lenalidomide capsules 5mg

Each capsule to contain Lenalidomide 5mg

Note:


37 SR No 00700601

Item Bipha.Isoph.Insulin(Human)inj.30/70 490,839 Vials

Specification Biphasic Isophane Insulin injection BP,1000 IU / 10ml.

Each 10ml rubber capped multidose vial to contain 100 IU/ml

(Human 30% as

soluble 70% as Isophane ) suspention of Human insulin complexed

with Protamin

sulphate in a solution of Human Insulin.

Note:

1.This injection should be stable for a minimum of 02 years when

stored within

the temperature range of 2'C - 8'C .

2.Manufacturer should confirm the product is free of HIV and

Hepatitis virus.

3.This injection to be presented in airtight tamper proof vial.


Page No 7 of 89




NO OF ITEMS 418


ITEM QUANTITY

38 SR No 00902901

Item Bimatoprost ophthalmic susp.300mcg/ml,3ml 42,246 Vials

Specification Bimatoprost ophthalmic suspension 300mcg/ml, 3ml dropper bottle

Each 3ml dropper bottle to contain 300mcg/ml of Bimatoprost for

ophthalmic use

Note:

01.The tamper - evident container (dropper bottle) should assure the



03.Each dropper bottle should be labelled accordingly

39 SR No 00405401

Item Calcium 500mg+Vitamin D3250IU Tab 1,887,513 Tabs

Specification Calcium 500mg + Vitamin D3 250IU Tablet

Note:


40 SR No 01100103

Item Paraffin ,White Soft 9,583,125 gs

Specification White Soft Paraffin BP

OR

Petrolatum USP (white)

Note:

01.The product should be suitable for storage at a temperature range

of 28'C-32'C.


41 SR No 01206302

Item Lenalidomide capsule 10mg 23,631 Caps

Specification Lenalidomide capsules 10mg

Each capsule to contain Lenalidomide 10mg

Note:


42 SR No 00700701

Item InsulinIsophane(human)1,000IU/10ml 12,351 Vials

Specification Isophane Insulin injection BP (NPH Insulin) derived from human

1000IU in 10ml.

OR

Isophane Insulin suspension USP (NPH Insulin) derived from huaman

1000 IU/10ml.

Each rubber capped multidose Vial to contain 1000 IU/10ml of sterile

purified

suspension of Isophane Insulin BP/USP derived from human.

Note:

1. This injection should be stable for a minimum of 24

months when stored within 2'C - 8'C.

2. Do not allow to freeze.


Item Clobazam tablet 5mg 503,001 Tabs

Specification Clobazam tablet 5mg

Each tablet to contain 5mg of Clobazam BP.

Note:


44 SR No 00202102

Item Bosentan tablet 62.5mg 63,660 Tabs

Page No 8 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Bosentan tablet 62.5mg

Each tablet to contain 62.5mg of Bosentan

Note:


45 SR No 00202001

Item Sodium nitroprusside Inj. 50mg 189 Vials

Specification Sodium Nitroprusside for Injection BP/USP 50mg

Each vial to contain Sodium Nitroprusside BP/USP equivalent to

50mg of

dehydrated Sodium Nitroprusside as powder for reconstitution with

suitable

solvent for intravenous injection.

Note:


months when stored at a temperature range of 28'C-32'C

2. Each vial should be labelled accordingly46 SR No 01205702

Item Rituximab injection500mg/50ml vial 3,780 Vials

Specification Rituximab Injection 500mg in 50ml

Each 50ml vial to contain 500mg of Rituximab for intravenous

infusion.

Note:


2 years when stored within a temperature range of 2'C - 8'C


Item Gemcitabine hydrochlorideinj.200mg 2,655 Vials

Specification Gemcitabine Hydrochloride Injection 200mg Vial

Each vial to contain Gemcitabine Hydrochloride as sterile dry powder

for

reconstitution with water for injection for intravenous injection or

intravenous

infusion.

1. The product should be stable for minimum of 24 months when

stored under

storage condition specified by the manufacturer.

2. Each vial to be labelled accordingly.48 SR No 01502101

Item Lignocaine injection 2%, 5ml vial 53,118 Vials

Specification Lignocaine Injection BP/Lignocaine Injection BP 2% w/v,5ml.

Each 5ml amber coloured vial to contain 2% w/v sterile solution of

Lidocaine Hydrochloride BP for local anaesthesia

OR

Lidocaine Hydrochloride Injection USP 2% w/v,5ml

Each 5ml amber coloured vial to contain 2% w/v sterile solution of

Lidocaine Hydrochloride USP for local anaesthesia.

Note:


years when stored at a temperature range of 28'C-32'C

2.This injection should comply with the "No. 15.4(d)

labelling for anaesthetic products"


Item Oxybutynine Hydrocloride Tab5mg 58,557 Tabs

Page No 9 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Oxybutynine tables BP 5mg

Each tablet to contain Oxybutynine Hydrocloride BP 5mg

OR

Oxybutynine Chloride tablets USP 5mg

Each tablet to contain Oxybutynine Chloride USP 5mg

Note:


50 SR No 01204901

Item Paclitaxel injection 30mg/5mlvial 18,138 Vials

Specification Paclitaxel Injection 30mg in 5ml vial

Each 5ml, sterile solution to contain 30mg of Paclitaxel for

intravenous infusion

Note:


stored under manufacturer's conditions.

2.Each vial should be labeled accordingly.

3.One set of administration device and suitable diluent compatible

with Paclitaxel injection,to be supplied with every

six vials of Paclitaxel injection.

Administration device sets should be

3.1.Free from Polyvinyl Chloride (PVC) and di-(2-ethylhexyl) Phthalate

(DEHP)

3.2.Contain needle, in line filter with a microspores membrane not

greater than 0.22 micrometer and a poly

ethylene- lined.51 SR No 00000804

Item Morphine Sulphate CR tab 10mg 160,416 Tabs

Specification Morphine sulphate Controlled Release Tablets 10mg.

Each tablet to contain 10mg of Morphine Sulphate BP/USP

in a suitable controlled release form.

Note:


02.product should be stored in an air tight light resistant container.

52 SR No 01301201

Item Clotrimazole pessaries 100mg 32,208 Pessas

Specification Clotrimazole Pessaries 100mg BP

Each vaginal tablet to contain 100mg of Clotrimazole BP.

OR

Clotrimazole vaginal insert 100mg USP

Each vaginal insert to contain 100mg of Clotrimazole USP.

Note:

01. The shelf life of the product should be minimum of 24 months.

53 SR No 01100101

Item Paraffin, liquid 8,282,091 mls

Specification Liquid Paraffin BP( Heavy)

OR

Mineral Oil USP( Heavy)

Pack: 1000 ml in a well closed container

Note:


54 SR No 00102102

Item Meropenem Inj. 1g vial 389,529 Vials

Page No 10 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Meropenem Injection 1g vial

Each vial shall contain sterile Meropenem Trihydrate BP/USP

equivalent

to 1g of anhydrous Meropenem as sterile dry white powder for

reconstitutions

with sterile diluent for intravenous injection or infusion.It shall

contain

90mg (3.9mmol) of Sodium for each gram of Meropenem.

Note:

1.This injection should be stable for minimum of 24 months when

stored below 30'C55 SR No 00304501

Item Topiramate Tab. 25mg 1,553,424 Tabs

Specification Topiramate Tablet 25mg

Each coated tablet to contain Topiramate 25mg

Note:


56 SR No 00500204

Item Fluticson+SalmetrolInha.125/25md,120 d 31,398 Inhals

Specification Fluticasone propionate 125mcg with Salmeterol xinafoate 25mcg /

metered dose,120

dose unit


suitable propellents

to contain suspension of fluticosone propionate 125mcg with

salmeterol xinafoate

25mcg BP.

To deliver 125mcg of fluticosone propionate with salmeterol

xinafoate 25mcg per

metered inhalation.

Note:

1. Each non-reactive areosol container equipped with metered dose

valve,to be


2. Tenders should give detail specifications of the product offered

along with

sample.57 SR No 01205401

Item Cyclosporin capsule 25mg 257,451 Caps

Specification Cyclosporin Capsules USP 25mg.

Each capsule to contain 25mg of Cyclosporin USP.

Note:


58 SR No 00406702

Item Cholecalciferol capsule1000 IU(25 mcg)(Colecalciferol) 213,399 Caps

Specification Colecalciferol capsule BP 1000 IU (25 micrograms)

Each coated capsule to contains 1000 IU of Colecalciferol BP

Note:


02.The product should be protected from light.

59 SR No 01202801

Item Folinic acid tablet 15mg 11,814 Tabs

Page No 11 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Leucovorin Calcium Tablets USP, 15mg

Each tablet to contain 15mg of Leucovorin Calcium USP.

Note:


60 SR No 00701301

Item Propylthiouracil tablet 50mg 97,263 Tabs

Specification Propylthiouracil tablets BP 50mg

Each tablet to contain 50mg of Propylthiouracil BP

Tablet should also conform to dissolution test for Propylthiouracil

tablets as

per USP

OR

Propylthiouracil Tablets USP 50mg

Each tablet to contain 50mg of Propylthiouracil USP.

Note:


61 SR No 00500403

Item Ipratropium Br. Resp.sol0.25mg/1ml,15ml 96,003 Vials

Specification Ipratropium Bromide respiratory solution, 250mcg in 1ml, 15ml.

Each 15ml vial to contain 250mcg/ml of Ipratropium Bromide

BP(2000) in suitable base for use in nebuliser.

Note : (1) Each vial should be labelled accordingly.

62 SR No 01100201

Item Wax,emulsifying 6,723 kgs

Specification Emulsifying Wax BP

OR

Emulsifying Wax USNF

Note:


63 SR No 00801201

Item Bisacodyl tablet 5mg 1,477,776 Tabs

Specification Bisacodyl tablets BP/USP, 5mg

Each enteric-coated tablet to contain 5mg of Bisacodyl BP/USP

Note:


64 SR No 00306901

Item Aripiprazole tablet 10mg 408,726 Tabs

Specification Aripiprazole tablets 10mg

Each tablet to contains 10 mg of Aripiprazole

Note:


65 SR No 01400903

Item Leflunomide tab.20 mg 208,644 Tabs

Specification Leflunomide tablets 20mg

Each coated tablet to contain 20mg of Leflunomide

Note:


66 SR No 00000810

Item Morphine sulphate syrup2mg in 1ml, 100ml bottle 1,908 Bots

Page No 12 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Morphine Sulfate Oral solution (BP) 2mg/1ml 100ml bottle,

Each 100ml bottle to contain 2mg/1ml of Morphine Sulfate BP/USP in

a suitable flavored and sweetened syrup/suspension base.

Note:

01.Product should be free from alcohol

02.The product should be stable for 24 months when stored at 28'C-

32'C

03.The product should be protected from light

67 SR No 00303104

Item Ondansetron tablet 4mg 198,006 Tabs

Specification Ondansetron tablet BP 4mg

Each coated tablet to contain Ondansetron Hydrocloride Dihydrate

BP

equivalent to 4mg of Ondansetron Hydrocloride Dihydrate

Note:


68 SR No 00203901

Item Dobutamine Inj. 250mg/20ml 57,462 Vials

Specification Dobutamine for Injection USP 250mg/20ml vial.

Each vial to contain Dobutamine Hydrochloride USP equivalent to

250mg of

Dobutamine with suitable diluent for intravenous infusion.

OR

Dobutamine Injection USP 250mg/20ml vial.

Each 20ml vial to contain Dobutamine Hydrochloride USP equivalent

to 250mg of

Dobutamine Hydrochloride in water for injection USP.

Note:

1.The injection should be stable for a minimum of 24

months when stored at a temperature range of 28'C-

32'C/Manufacturer's prescribed storage

conditions.

2.Each vial should be labelled accordingly.69 SR No 00201901

Item Sildenafil Tab. 50mg 373,665 Tabs

Specification Sildenafil Tablet 50mg

Each Tablet to contain 50mg of Sildenafil

Note:


70 SR No 00903001

Item Brinzolamide eye drops 1%,5mlvial 31,134 Vials

Specification Brinzolamide eye drops 1%,in 5ml dropper bottle

Each 5ml dropper bottle to contain 1% w/v Brinzolamide for

ophthalmic use

Note:






Item Doxycycline hydrochlorideCap. 100mg 2,497,767 Caps

Page No 13 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Doxycycline capsules BP/USP 100mg

Each capsule to contain Doxycycline hydrochloride BP/USP


Doxycycline.

Note:

1.The product should conform to bio equivalence criteria Of the

WHO.


72 SR No 01002001

Item 0.2% Chlorhexidine Mouth Wash100ml bottle 44,976 Bots

Specification Chlorhexidine 0.2% Mouth Wash,100ml bottle.

Each bottle to contain 0.2% w/v of Chlorhexidine gluconate mouth

wash

Note:


02. Each bottle should be labelled accordingly

73 SR No 01205001

Item Irinotecan injection 40mg/2ml 894 Vials

Specification Irinotecan hydrochloride trihydrate Injection 40mg in 2ml Vial

Each 2ml vial to contain Irinotecan hydrochloride trihydrate

equivalant to 40mg

of Irinotecan hydrochloride for intravenous use.

Note:

1.The injection should be stable for a minimum of 24 months when



Item Midazolam maleate Tab. 7.5mg 10,431 Tabs

Specification Midazolam maleate tablet 7.5mg

Each tablet to contain 7.5mg of Midazolam BP

Note;

1.This preparation should be stable for minimum of 24

months75 SR No 00201301

Item Bisoprolol fumarate Tab. 5mg 8,553,225 Tabs

Specification Bisoprolol fumarate tablets 5mg

Each tablet to contain Bisoprolol fumarate 5mg

Note:


76 SR No 01101901

Item Fluocinolone cream 0.025%,15g tube 53,076 Tubes

Specification Fluocinolone Cream BP 0.025%, W/W in 15g

Each 15g collapsible tube to contain 0.025% (w/w) of Flucinolone

Acetonide BP

in suitable cream base

OR

Flucinolone Acetonide Cream USP 0.025% W/W in 15g

Each 15g collapsible tube to contain 0.025% (w/w) of Flucinolone

acetonide USP

in suitable cream base.

Note:

1.This product should be stable for a minimum of 24

months when stored at a temperature range of 28'C - 32'C.

2.Each collapsible tube should be labelled accordingly.

Pack: 15g in air tight, sealed, printed collapsible tubes, in printed

cartons

Page No 14 of 89




NO OF ITEMS 418


ITEM QUANTITY

77 SR No 01205701

Item Rituximab injection100mg/10ml vial 2,712 Vials

Specification Rituximab Injection 100mg in 10ml Vial

Each 10ml vial to contain 100mg of Rituximab for intravenous

infusion.

Note:


2 years when stored within a temperature range of 2'C - 8'C


Item Thiopentone sodium Inj. 500mg 2,415 Vials

Specification Thiopentone Injection BP 500mg

OR

Pentothal Sodium for injection USP 500mg

Each vial to contain 500mg of Thiopentone Sodium BP Pentothal

Sodium USP as sterile dry powder for reconstitution with

water for injection BP/USP for intravenous

use.

Note;

1.This injection should be stable for minimum of 24


2.This injection should comply with the "No.15.4(d),

labeling for anesthetic products" of this tender

documents.

3.Each ampoule should be labeled accordingly.

79 SR No 01204802

Item Docetaxel injection 80mg vial 8,577 Vials

Specification Docetaxel Injection, 80mg/2ml

Each vial to contain 80mg of Docetaxel for reconstitution with

suitable diluent

for intravenous infusion

Note:

1.To be supplied with suitable diluent.

2.The injection should be stable for minimum of 24 months when

stored under


3.Each vial to be labelled accordingly.80 SR No 00302003

Item Risperidone tablet 1mg 1,096,599 Tabs

Specification Risperidone tablet 1mg

Each coated tablet to contain 1mg of Risperidone BP/USP

Note:


81 SR No 00201501

Item Labetalol HCl Tab. 100mg 185,061 Tabs

Specification Labetalol Hydrochloride Tablet BP/USP 100mg

Each tablet to contain 100mg of Labetalol Hydrochloride BP/USP

Note:


82 SR No 00103903

Item Trimethoprim Tab. 200mg 5,655 Tabs

Page No 15 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Trimethoprim tablet 200mg

Each tablet to contain 200mg of Trimethoprim BP/USP

Note:


83 SR No 00902201

Item Methylcelulose for intraocul.use 2%,5ml 29,544 PF.Syrs

Specification Hydroxypropylmethylcellulose Ophthalmic Solution for Intra-Ocular

use in 5ml

prefilled syringe

Each 5ml Pre-filled syringe to contain 2%w/v sterile solution of

Hydroxypropylmethylcellulose for intraocular use

Note:


84 SR No 01205402


Specification Cyclosporin Capsules USP 50mg.

Each capsule to contain 50mg of Cyclosporin USP.

Note:


85 SR No 00302902

Item Venlafaxine HCl Cap. E.R. 75mg 2,040,351 Caps

Specification Venlafaxine Hydrochloride extended release capsules 75mg

Each extended release capsule to contain 75mg of Venlafaxine

Hydrochloride

Note:


86 SR No 01601301

Item Atropine sulphate inj.15mg/25ml vial 7,899 Vials

Specification Atropine Injection BP 15mg in 25ml vial

Each 25ml vial to contain 15mg of Atropine Sulphate BP in water for

injection BP/USP for intravenous use

OR

Atropine Sulphae injection USP 15mg in 25ml vial.

Each 25mg vial to contain 15ml of Atropine Sulphate USP in water for

injection BP/USP for intravenous use.

Note:

1.This injection should be stable for 2 years when



Item Cadioplegia infusion(St.Thomas Sol) 1,599 Amps

Specification Cadioplegia infusion bulb(St. Thomas Solution)

1.Should be Packed individually and labelled accordingly


88 SR No 00305801

Item Duloxetine(hydrochloride)20 mgCapsules 280,857 Caps

Specification Duloxetine (as hydrochloride) 20 mg Capsules

Each capsule to contain 20mg of Duloxetine hydrochloride BP

Note:


89 SR No 00301901

Item Olanzapine Tab.5mg 2,552,601 Tabs

Page No 16 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Olanzapine tablet 5mg

Each coated tablet to contain 5mg of Olanzapine

Note:


90 SR No 00303703

Item Phenytoin sodium Tab. 100 mg 4,178,700 Tabs

Specification Phenytoin sodium tablets BP/USP 100mg

Each coated tablets to contain 100mg of Phenytoin sodium BP/USP

Note:


91 SR No 00901702

Item Timolol Eye Drop 0.5%,5ml 84,177 Vials

Specification Timolol maleate Eye Drops BP 0.5%, w/v

OR

Timolol Maleate Ophthalmic solution USP, 0.5% w/v

Each 5ml dropper bottle to contain Timolol Maleate BP/USP

equivalent to 0.5% w/v

of Timolol in an aqueous solution.

Note:

1.The sealed tamper evident dropper bottle should assure the

sterility of the

product.

2.Product should be packed in light resistant containers/boxes.

3.Product should be stable for a minimum of 24 months when stored

within a

temperature range of 28'C - 32'C.

4.Each botle should be labelled accordingly.92 SR No 01202702

Item Etoposide injection 100mg vial 5,373 Vials

Specification Etoposide Injection USP 100mg/5ml

Each 5ml amber coloured vial to contain 20mg/ml of Etoposide

BP/USP for

intravenous injection. Should be diluted before use.

Note:


months when stored at a temperature range of 28'C - 32'C


Item Vasopressin Inj. 20 I.U./1mlampoule 6,924 Amps

Specification Vasopressin Injection USP,20 IU in 1ml ampoule

Each 1ml glass ampoule to contain 20IU of an aqueous solution of

synthetic

vasopressin USP for subcutaneous,intramuscular injection or

intravenous

infusion.

Note;

1. This Injection should be stable for a minimum of 24

months when stored with in the temperature range of

2'C - 8'C. Do not freeze.

2. Each ampoule should be labelled accordingly.94 SR No 01203801

Item Oxaliplatin injection 50mgvial 3,510 Vials

Page No 17 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Oxaliplatin for injection 50mg as lyophilized powder

Each vial to contain 50mg of sterile, preservative free lyophylized

reconstitution powder of Oxaliplatin for intravenous injection.

OR

Oxaliplatin injection 50mg in 10ml vial

Each 10ml vial to contain sterile, concentrated solution of 5mg /1ml

Oxaliplatin in water for injection BP/USP, suitable for intravenous

infusion

after dilution.

Note;

1.The preparation should be stable for minimum of 24

months when stored under storage condition specified

by the manufacturer.

2.Each vial should be lablled accordingly

95 SR No 00701801

Item Methyl Prednisolone tablet 4mg 426,900 Tabs

Specification Methylprednisolone tablets BP/USP 4mg

Each tablet to contain 4mg of Methylprednisolone BP/USP

Note:


02. The Product should be protected from light.

96 SR No 01100102

Item Paraffin,yellow soft 69,376,587 gs

Specification Yellow Soft Paraffin BP

OR

Petrolatum USP (Yellow)

Note:

01.The product should be suitable for storage at a temperature range

of 28'C-32'C.


97 SR No 00302801

Item Sertraline tablet 50mg 2,628,615 Tabs

Specification Sertraline tablet 50mg

Each tablet to contain 50mg of Sertraline

Note:


98 SR No 00901501

Item Tropica.0.8%+Phenyleph.5%,5mlEye Drop 16,221 Vials

Specification Tropicamide 0.8% with Phenylephrine Hydrochloride 5% eye drops

5ml

Each 5ml amber coloured dropper bottle to contain 0.8% of

Tropicamide BP/USP and

5% of Phenylephrine Hydrochloride BP/USP in purified water.

Note:



2.Each bottle should be packed in light-resistant boxes.




Item Diazepam rectal solution5mg/2.5ml 4,452 Tubes

Page No 18 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Diazepam rectal solution 5mg in 2.5ml Tube

Each 2.5ml tube to contain 5mg of Diazepam BP/USP as solution for

rectal use.

Note:

01.The tube should be suitably formulated for rectal use.


100 SR No 00205404

Item Aspirin enteric coated tablet75mg 79,165,287 Tabs

Specification Aspirin enteric coated tablets BP, 75 mg blister pack

Each Gastro-resistant tablet to contain 75mg of Aspirin BP.

OR

Aspirin delayed-release tablets USP 75mg blister pack

Each tablet to contain 75mg of Aspirin USP.

Note:


101 SR No 01502104

Item Lignocaine spray10% ,50mlbottle 1,743 Bots

Specification Lidocaine topical aerosol USP, 10% w/v

Each 50ml bottle to contain Sterile solution of Lidocaine in suitable

vehicle with

suitable propellants in a pressurized container equipped with a

metering valve

to deliver 5mg to 10mg of Lidocaine USP per metered dose.

Note:

1.Minimum of 500 doses should be filled in non-reactive

aerosol container equipped with metered dose valve.102 SR No 01500301

Item Propofol for IV use 20ml ampoule/vial 69,444 Amps

Specification Propofol 1% injection for intravenous infusion 20ml ampoule/vial

Each 20ml ampoule/vial to contain 1% W/V of Propofol as an sterile

oil in water emulsion

for intravenous infusion.

Note;




labelling for anaesthetic products" of this tender

documents.

3.Each ampoule/vial should be labelled accordingly

103 SR No 01201703

Item Cytarabine injection1g in 10ml vial 1,380 Vials

Specification Cytarabine Injection BP 1g/10ml, (Not for intrathecal use)

Each 10ml vial to contain 1g of Cytarabine BP in water for injection

BP/USP

OR

Cytarabine for Injection USP 1g, (Not for intrathecal use)

Each vial to contain 1g of Cytarabine BP/USP as sterile dry powder for

reconstitution with water for injection BP/USP

before use for intravenous and subcutaneous use

Note:

1.This injection should be stable for 24 months when stored at a

temperature within 28'C-32'C.


Item Ifosfamide1g vial+Mesna 100mgin 1ml, 3 amps in one set 4,458 Sets

Page No 19 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification (A) Sterile Ifosfamide injection USP 1g vial

Each vial to contain 1g of Ifosfamide USP as sterile dry powder for

reconstitution with water for injection BP/USP before use for

intravenous

injection or intravenous infusion in the correct (1:3) combination

with Mesna

for injection(B).

(B) Mesna for injection 100mg in 1ml

Each 1ml Vial to contain 100mg of Mesna for intravenous injection or

intravenous

infusion

Pack : 1 vial of A and 3 vials of B in a set.

Note:

1.These injections should be stable for a minimum of 24

months when stored under manufacturer's conditions.


105 SR No 00407201

Item Total Parenteral Nutrition in1000ml -2500ml collapsible bag 6,480 Bags

Specification Total Parenteral Nutrition in 1,000ml -2,500ml, multiple component

in collapsible bag (central or peripheral)

Each collapsible bag to contain 675 kcal/L of Energy (350 kcal/L of

Lipid, 95 kcal/L of Amino acid, 230 kcal/L of

Dextrose ). PH should be 5.6 and Osmolarity should be 750 mOsm/L.

Note:

01. Each collapsible bag should be labeled accordingly.

02. The shelf life of the product should be minimum of 24 months

106 SR No 00200306

Item Furosemide Syrup 20mg/5ml,sugar free150ml bottle 1,626 Bots

Specification Furosemide oral solution USP 20mg/5ml , 150ml bottle

Each 150ml to contain 20mg/ 5ml Furosemide BP /USP in a suitable

flavoured and sweetened syrup base

Note:

1. The preparation should be free from sugar.


3. The product should be protected from light

107 SR No 00200701

Item Amiodarone Tab. 100mg 702,519 Tabs

Specification Amiodarone Tablets BP, 100mg

Each tablet to contain 100mg of Amiodarone Hydrochloride BP

Note:


108 SR No 01300401

Item Levonorgestrel 20mcg/24h I/Usystem 1,377 Devices

Specification Levonorgestrel impregnated Intra uterine device releasing

Levonorgestrel

20mcg/24h.

Each Levonorgestrel impregnated Intra uterine device to release

Levonorgestrel

20mcg/24h.

Note:


Page No 20 of 89




NO OF ITEMS 418


ITEM QUANTITY

109 SR No 01300202

Item Oxytocin injection 5 I.U. /1ml amp 454,929 Amps

Specification Oxytocin Injection BP/USP, 5IU/1ml.

Each 1ml ampoule to contain 5IU of synthetic Oxytocin BP/USP in

water for injecion BP/USP for subcutaneous,

intramuscular, slow intravenous injection and intravenous infusion.

Note:


stored with in the temperature range of 2'C - 15'C.

Do not freeze.

2.Each ampoule should be pre-filed.

3.Each ampoule should be labelled accordingly

110 SR No 01102401

Item Mupirocin 2% ointment 5g tube 21,447 Tubes

Specification Mupirocin 2% Ointment 5g tube

Each 5g tube to contain 2% Mupirocin BP/USP in a suitable basis.

Note -

01.The product should be preserved in collapsible and well-closed

tubes


111 SR No 00107101

Item Fluconazole Cap. 50mg 474,363 Caps

Specification Fluconazole capsule 50mg

Each capsule to contain 50mg of Fluconazole.

The Capsule should conforms to bio equivalence criterion Of the

WHO

Note:


112 SR No 01207402

Item Octreotide inj. 50mcg in 1mlamp 20,283 Amps

Specification Octreotide injection 50mcg in 1ml

Each 1ml ampoule to contain 50mcg of Octreotide Acetate as sterile

solution for

subcutaneous injection or intravenous injection

Note:


temperature range of 28'C - 32'C


Item Calcium lactate Tab. 300mg 59,904,336 Tabs

Specification Calcium Lactate tablet BP 300mg.

Each tablet to contain the equivalent of 300mg of Calcium Lactate

pentahydrate.Tablet should also conform to dissolution test for

Calcium Lactate

tablets as per USP.

OR

Calcium Lactate tablet USP, 300mg.

Each tablet to contain the equivalent of 300mg of Calcium Lactate

pentahydrate.

Note:


114 SR No 00500107

Item Salbutamol MDI100mcg/md,200 doses 339,666 Inhals

Page No 21 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Salbutamol pressurized inhalation BP 100mcg/metered dose.(200

doses)


suitable

propellants,to contain suspention of either Salbutamol or Salbutamol

Sulphate BP

to deliver 100mcg of Salbutamol per metered inhlation.

Note:

1.Each non-reactive aerosol container equipped with

metered dose valve,to be filled with 200 doses.

2.Tenderers should give detail specifications of the

product offered along with samples.115 SR No 00403001

Item Calcitriol Cap. 250ng 2,233,464 Caps

Specification Calcitriol Capsules BP, 250ng

Each capsule to contain 250ng of Calcitriol BP in a suitable fixed oil.

Note:


116 SR No 01206401

Item Thalidomide capsule 100mg 59,463 Caps

Specification Thalidomide Capsule USP 100mg

Each capsule to contain 100mg of Thalidomide USP

Note:


117 SR No 01100601

Item Dithranol Powder 3,855 gs

Specification Dithranol BP(As fine powder)

50g in a well closed container

Note:


118 SR No 01206901

Item Letrozole tablet 2.5mg 137,124 Tabs

Specification Letrozole Tablet 2.5mg

Each coated tablet to contain Letrozole 2.5mg

Note:


119 SR No 01202204

Item Methotrexate injection 1g vial 2,226 Vials

Specification Methotrexate injection BP/USP 1g/10ml

Each 10ml vial to contain Methotrexate Sodium BP/USP equivalent to

100mg/ml

Methotrexate in water for injection BP/USP for intramuscular,

intravenous use.

OR

Methotrexate for injection USP 1g

Each vial to contain Methotrexate Sodium USP/BP equivalent to 1g of

Methotrexate

as sterile freeze dried powder for reconstitution with water for

injection

BP/USP for intramuscular, intravenous use.

Note:

1. This injection should be stable for minimum of 24


2. Each vial should be labelled accordingly.

Page No 22 of 89




NO OF ITEMS 418


ITEM QUANTITY

120 SR No 00500205

Item Fluticson+SalmetrolInha.250/25md,120d 231,843 Inhals


metered dose,120

dose unit

Each Pressurized container equipped with metering valve and

sutiable propellants

to contain suspension of fluticosone propionate250mcg with

salmeterol xinafoate

25mcg BP

to deliver 250mcg of fluticosone propionate with salmeterol

xinafoate 25mcg per

metered inhalation.

Note:

1. each non-reactive areosol container equippied with metered dose

valve,to be



along with

samples.121 SR No 00201702

Item Hydralazine HCl Inj. 20mg/1ml 3,708 Amps

Specification Hydralazine Injection BP/USP 20mg.

Each 1ml ampoule to contain 20mg of Hydralazine Hydrochloride

BP/USP for

intravenous infusion (Not in dextrose) slow intravenous injection and

intramuscular injection.

Note:




122 SR No 01500802

Item Atropine Sulphate inj.0.1mg/mlin 10ml pre-filled syringe 891 PF.Syrs

Specification Atropine Injection BP 0.1mg/ml in 10ml pre-filled syringe

Each 10ml pre-filled syringe to contain 1mg of Atropine Sulphate BP

in water for injection BP/USP for subcutaneous,

intramuscular or intravenous use

OR

Atropine Sulphate injection USP 0.1mg/ml in 10ml pre-filled syringe

Each 10ml pre-filled syringe to contain 1mg of Atropine Sulphate USP

in water for injection BP/USP for subcutaneous,

intramuscular or intravenous use.

Note:


temperature range of 28'C-32'C

2.Each pre-filled syringe should be labelled accordingly.

123 SR No 00401005

Item Sodium chloride IV infusion 0.9% 1000ml collapsible bag 32,541 Bags

Page No 23 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Sodium Chloride intravenous infusion BP 0.9% w/v

OR

Sodium Chloride injection USP, 0.9% w/v

Each 1000ml collapsible bag to contain 0.9% w/v of Sodium Chloride

BP/USP in water for injection BP/USP for intravenous

infusion.

Note:

1. The collapsible bag should be graduated to 1000 ml and be made

of medicinal grade Polyethylene or Polypropylene. PVC

is not acceptable.

2. The collapsible bag should have a device for hanging.

3. To prevent leakage of fluid with insertion or withdrawal of spike or

continuous use the site of the insertion of

piercing spike should be covered with a sterile rubber disk or bung

and the plastic cover of the disk or bung should

be fused to neck of the collapsible bag right round.

4. Each collapsible bag should be packed individually in a protective

polyethylene cover.

5. The product should be sterile and stable for a minimum of 24

months within a temperature range of 30 C- 35 C.

6. The collapsible bag should be labelled accordingly.124 SR No 00702501

Item Norethisterone tablet 5mg 1,210,101 Tabs

Specification Norethisterone Tablets BP 5mg

Each tablet to contain 5mg of Norethisterone BP

OR

Norethindrone Tablets USP 5mg

Each tablet to contain 5mg of Norethindrone USP.

Note:


125 SR No 00204702

Item Enoxaparin Inj.60mg/0.6mlPF.Syringe 300,771 PF.Syrs

Specification Enoxaparin Sodium injection, 6,000 IU in 0.6ml prefilled syringe/vial

Each 0.6ml prefilled syringe or vial to contain 6,000 IU of Enoxaparin

Sodium

BP/Ph Eur/USP, salt of a low molecular weight Heparin obtained by

depolimerization

of Heparin for subcutaneous and intravenous injection.

Note;

1.The poduct to be stable for minimum of 24 months when

stored under storage condition stipulated by the

manufacturer.

2.Each vial or syringe to be labelled accordingly.

126 SR No 01301802

Item Tolterodine sustained release capsule 2mg 20,163 Caps

Specification Tolterodine sustained release capsule 2mg

Each sustained release capsule to contain 2mg of Tolterodine

Note:


127 SR No 00500206

Item Fluticasone + Salmeterolinha 50mcg /25mcg md,120d 6,504 Inhals

Page No 24 of 89




NO OF ITEMS 418


ITEM QUANTITY


metered dose,120 dose unit

Each Pressurized container equipped with metering valve and

sutiable propellants

to contain suspension of fluticosone propionate with salmeterol

xinafoate

BP, to deliver 50mcg of fluticosone propionate with 25mcg of

salmeterol xinafoate per

metered inhalation.

Note:

1. each non-reactive areosol container equippied with metered dose

valve,to be



along with128 SR No 00706602

Item Estradiol valerate tablet 2mg 4,908 Tabs

Specification Estradiole valerate tablet 2mg

Each coated tablet to contain 2mg of Estradiol valerate USP

Note:


02.The product should store in the original package in order to

protect from light and moisture.

03.Each calendar pack should contains 28 tablets

129 SR No 00301801

Item Clozapine Tab. 100mg 1,731,600 Tabs

Specification Clozapine tablet 100mg

Each tablet to contain 100mg of Clozapine BP/USP

Note:


130 SR No 00904101

Item Moxifloxacin ophthalmicsolutn. 0.5%,5ml 42,747 Vials

Specification Moxifloxacin hydrochloride ophthalmic solution 0.5% w/v , 5ml

dropper bottle

Each 5ml dropper bottle to contain 0.5% w/v of Moxifloxacin

hydrochloride in

purified water with suitable preservative for ophthalmic use.

Note:







Item Azathioprine tablet 50mg 1,089,462 Tabs

Page No 25 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Azathioprine tablets BP 50mg

Each tablet to contain 50mg of Azathioprine BP

Tablet should also conform to dissolution test for Azathioprine

tablets as per

USP

OR

Azathiprine Tablet USP 50mg

Each tablet to contain 50mg of Azathiprine USP

Note:


132 SR No 00701604

Item Dexamethasone Tablet 8 mg 48,576 Tabs

Specification Dexamethazone Tablets BP 8mg

Each tablet to contain 8mg of Dexamethazone BP

Tablet should also conformed to dissolution test

for Dexamethazone Tablets as per USP

OR

Dexamethazone Tablets USP 8mg

Each tablet to contain 8mg of Dexamethazone USP

Note :

01.Tablets should be scored


133 SR No 00400303

Item Iron Drops 50mg/ml,in 15ml dropper 82,173 Bots

Specification Iron Drops 50mg/ml, in 15ml dropper bottle.

Each 15ml dropper bottle to contain Polysacharide Iron complex

equivalent to 50mg/ml of Iron for paediatric use.

Note:




Item Ofloxacin Tab. 200 mg 89,700 Tabs

Specification Ofloxacin tablet 200 mg

Each tablet to contain 200 mg of Ofloxacin BP/USP.

Note:


135 SR No 00305002

Item Co-careldopa Tab. 25/250mg 1,511,865 Tabs

Specification Co-careldopa tablets BP 25/250mg

Each tablet to contain 250mg of Levodopa BP, and carbidopa BP

equivalent to 25mg

of Anhydrous Carbidopa

OR

Carbidopa and Levodopa tablets USP 25/250mg

Each tablet to contain 250mg of Levodopa USP and Carbidopa USP

equivalent to

25mg of Anhydrous Carbidopa.

Note:


136 SR No 00701101

Item Thyroxine tablet 50mcg 24,605,487 Tabs

Page No 26 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Levothyroxine tablets BP/Thyroxine tablets BP 50mcg

Each tablet to contain Levothyroxine sodium BP equivalent to 50mcg

of anhydrous

Levothyroxine Sodium

Tablet should also conform to dissolution test for Levothyroxine

Sodium tablets

as per USP

OR

Levothyroxine Sodium tablets USP 50mcg

Each tablet to contain Levothyroxine sodium USP eqivalent to 50mcg

of anhydrous

Levothyroxine Sodium

Note:

01.Sufficient overage to be added to ensure adequate shelf life.

Product should be

protected from light.


137 SR No 00600401

Item Meningococcal Vaccine singledose vial 1,206 Vials

Specification

Meningococcal Polysaccharide Tetravalent vaccine group A,C,Y and

W135

Each 0.5ml reconstituted single dose vaccine to contain 50mcg of

each of the

polysaccharide antigens to be given subcutaneously or

intramuscularly.

Suitable diluent to be supplied with the vaccine.

Note:

i.Vaccines recommended for bulk purchase by the WHO for UN

agencies will be

considered as an added advantage (WHO pre-qualified).

ii.The product should be from fresh stocks and each consignment

should be

prepared preferably from a single batch.

iii. The following documents should be submitted pre- shipment for

each lot of

vaccine despatched. (a).Invoice (b).Certificate of origin (c).Certificate

of

analysis.(d).Lot release certificate from National control

Laboratory(NCL) from

country of origin.(e).Summery lot protocols of production procedure

& quality

control testing. These documents should be submitted pre-shipment

to the

National Control Laboratory for Vaccines (MRI) in Sri Lanka.138 SR No 01104001

Item Hydrogen peroxide solution6%v/v 450ml 16,221 Bots

Specification Hydrogen Peroxide solution BP 6% w/v 450ml

To contain 6% w/v of Hydrogen Peroxide equivalent to 20 volume of

available

Oxygen, 450ml volume in 500ml bottle

Note:

1. Suitable stabilising agent should be added

2. Each bottle should be labelled accordingly.


Pack: 450ml volume in at least 500ml partly filled, light resistant

containers

Page No 27 of 89




NO OF ITEMS 418


ITEM QUANTITY

139 SR No 00302901

Item Venlafaxine HCl Cap. E.R.37.5mg 949,638 Caps

Specification Venlafaxine Hydrochloride extended release capsules 37.5mg

Each extended release capsule to contain 37.5mg of Venlafaxine

Hydrochloride

Note:


140 SR No 01103601

Item Cetrimide powder 500g tin 3,723 Tins

Specification Cetrimide BP (as powder)


Note:


141 SR No 00500109

Item Salbutamol resp.solu.0.5%,15ml 134,676 Vials

Specification Salbutamol Respiratory solution 5mg/ml.

Each 15ml vial to contain Salbutamol Sulphate BP equivalent to 0.5%

w/v of Salbutamol in suitable base for use with

nebulizer

Note:

Each vial should be labelled accordingly.142 SR No 00204701

Item Enoxaparin Inj.40mg/0.4ml PF.Syringe 249,759 PF.Syrs

Specification Enoxaparin Sodium injection, 4,000 IU in 0.4ml prefilled syringe/vial

Each 0.4ml prefilled syringe or vial to contain 4,000 IU of Enoxaparin

Sodium

BP/Ph Eur, salt of a low molecular waight Heparin obtained by

depolimerization


Note;



manufacturer.

2.Each vial or syringe to be labelled accordingly.

143 SR No 00405303

Item Albumin solution (human) 5%,500ml bottle 777 Bots

Specification Albumin solution BP/Ph Eur(human), 5% in 500ml bottle

Each 500ml bottle to contain 5% of Albumin solution BP and at least

95% of the Albumin Protein BP (Ph Eur) derived from

human plasma serum.

OR

Albumin Human USP 5% in 500ml bottle

Each 500ml bottle to contain 5% of Albumin Human USP and at least

95% of the Albumin Protein USP derived from human

plasma serum.

Note:

1.The product should ensure, at least two steps of virus inactivation

as recommended by WHO.

2.The product should be stable for minimum of 24 months

when stored at temperature below 25'C

3.Each bottle should be labeled accordingly144 SR No 00800404

Item Domperidone suppository 30mg 13,887 Supps

Page No 28 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Domperidone suppository 30mg

Each suppository to contain Domperidone maleate BP, equvalant to

30mg of

Domperidone in a suitable suppository base.

Note:


when stored

under tropical climatic conditions.


Item Haloperidol Tab. 5mg 780,249 Tabs

Specification Haloperidol tablets BP/USP, 5mg

Each tablet to contain 5mg of Haloperidol BP/USP

Note:


146 SR No 00700303

Item Gliclazide MR tablet 30mg 5,805,000 Tabs

Specification Gliclazide Modified Release tablets 30mg

Each modified release tablet to contain 30mg of Gliclazide.

Note:


147 SR No 00600601

Item Yellow fever vaccine 0.5mlsingle dose 2,160 Amps

Specification

Yellow fever vaccine of the live attenuated 17D strain of yellow fever

virus BP.

The freeze dried preparation should be provided with a suitable

diluent.

Packing: 0.5ml (single dose vial)

Note

i.Vaccines recommended for bulk purchase by the WHO for UN

agencies will be

considered as an added advantage (WHO pre qualified).

ii.The product should be from fresh stocks and each consignment

should be

prepared preferably from a single batch.

iii. The following documents should be submitted pre- shipment for

each lot of

vaccine despatched. (a).Invoice (b).Certificate of origin (c).Certificate

of

analysis.(d).Lot release certificate from National control

Laboratory(NCL) from

country of origin.(e).Summary lot protocols of production procedure

& quality

control testing. These documents should be submitted pre-shipment

to the

National Control Laboratory for Vaccines (MRI) in Sri Lanka.

iv.Each consignment should have a minimum shelf life of 20 months

at the time148 SR No 00701704

Item Prednisolone Syr.5mg / 5ml ,60ml 22,428 Bots

Page No 29 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Prednisolone Oral solution USP 5mg in 5ml, 60ml bottle

Each 5ml of solution to contain 5mg of Prednisolone USP

in a suitable flavored and sweetened syrup base

OR

Prednisolone Sodium Phosphate Oral solution BP 5mg in 5ml, 60ml

bottle

Each 5ml of solution to contain 5mg of Prednisolone Sodium

Phosphate BP in a suitable flavored and sweetened syrup base

Note:


02. The product should be free from alcohol and protected from

light.


149 SR No 00101503

Item Cefotaxime Inj . 500mg vial 102,045 Vials

Specification Cefotaxime Sodium for Injection BP 500mg

OR

Cefotaxime for Injection USP 500mg.

Each 500mg vial to contain sterile Cefotaxime Sodium BP/USP

equivalent

to 500mg of Cefotaxime as sterile dry powder for reconstitution with

Water for Injection BP/USP for intramuscular and intravenous use.

Note:


WHO.


stored at

a temperature range of 28'C-32'C


150 SR No 00100801

Item Flucloxacillin capsule 500mg 14,415,186 Caps

Specification Flucloxacillin capsule BP, 500mg

Each Capsule to contain Flucloxacillin Sodium BP equivalent to 500

mg of

Flucloxacillin.

Note:

01.Capsule should conform to bio equivalence criteria Of the WHO

02.shelf life of the product should be minimum of 24 months

151 SR No 01301401

Item Misoprostol Tablet200 micrograms 93,852 Tabs

Specification Misoprostol Tablet 200 mcg

Each tablet to contain 200 micrograms of misoprostol BP.

Note:


152 SR No 00102101

Item Meropenem Inj. 500mg vial 168,768 Vials

Page No 30 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Meropenem Injection 500mg vial

Each vial to contain 500mg of Meropenam Trihydrate as sterile dry

powder for

reconstitutions with water for injection BP/USP for intravenous

infusion or

intravenous injection

Note:


WHO.


stored

at a temperature range of 28'C-32'C


Item Amiodarone injection 150mg/3ml 19,473 Amps

Specification Amiodarone Intravenous infusion BP,150mg/3ml

Each 3ml ampoule to contain sterile, concentrated solution of, 50mg

/1ml of

Amiodarone Hydrochloride in water for injection BP/USP, suitable for

intravenous

infusion after dilution.

Note;

1.The preparation should be stable for minimum of 24

months when stored under storage condition specified


2.Each ampoule should be lablled accordingly154 SR No 00200601

Item Adenosine Inj. 6mg/2ml 3,723 Amps

Specification Adenosine Injection 6mg in 2ml Vial

Each 2ml vial to contain 6mg of Adenosine USP for Intravenous

Injection

Note:




Item Neostigmine injection0.5mg/1ml amp 14,847 Amps

Specification Neostigmine Injection BP

OR

Neostigmine Methyl Sulphate Injection USP for pediatric use.

Each 1ml amber coloured ampoule to contain 0.5mg of Neostigmine

Methyl Sulphate

BP or 0.5mg of Neostigmine Methyl Sulphate USP for Intramuscular

Intravenous or

subcutaneous use.

Note:



2.Each ampoule should be labelled accordingly.156 SR No 01102201

Item Silversulphadiazine Cream1%,500g 5,412 Jars

Specification Silver Sulphadiazine Cream USP 1%, w/w 500g

Each 500g jar to contain 1% w/w of silver sulphadiazine USP in an

suitable cream

base.

Note:



2.Each jar should be labelled accordingly.

Pack: 500g in air tight, wide-mouth jar

Page No 31 of 89




NO OF ITEMS 418


ITEM QUANTITY

157 SR No 01500602

Item Isoflurane 250ml bottle 8,853 Bots

Specification Isoflurane BP, 250ml

Isoflurane BP for inhalational anaesthesia, in 250ml bottle

Note;

1.This preparation should be stable for minimum of 24


2.This preparation should comply with the "No.14(D),


documents.

3.Each bottle should be labelled accordingly158 SR No 01101201

Item Bentonite 31,362 gs

Specification Bentonite BP/USP (as fine powder)


Note:


159 SR No 00302402

Item Clomipramine HCl Tab. 25mg 529,326 Tabs

Specification Clomipramine Hydrochloride Tablets 25mg

Each tablet to contain 25mg of Clomipramine Hydrochloride BP

Note:

01.Analitical methods applicable to this tablet form may be the one

given for clomipramine capsules BP


160 SR No 00100804

Item Flucloxacillin Syr.125mg/5ml100ml 92,502 Bots

Specification Flucloxacillin oral solution BP 125mg/5ml in 100ml bottle,

Each 100ml to contain 125mg/5ml of Flucloxacillin Sodium BP in

a suitable flavoured and sweetend syrup/suspension base

Note:


WHO


03.Each bottle should be labelled accordingly.

161 SR No 01500302

Item Propofol for IV use 50ml ampoule/vial 48,237 Amps

Specification Propofol 1% injection for intravenous infusion 50ml ampoul/vial

Each 50ml ampoule/vial to contain 1% W/V of Propofol as an sterile

oil in water emulsion

for intravenous infusion.

Note;





documents.

3.Each ampoule/vial should be labelled accordingly

162 SR No 00801401

Item Iso-Os.bowel(PEG+Elect) 39,327 Sachets

Specification Iso-Osmotic (Polyethylene glycol+Electrolytes) Bowel cleansing

Preparation to

use before double contrast radiological examinations & other related

procedures.(Pack of 4 Sachest).

Page No 32 of 89




NO OF ITEMS 418


ITEM QUANTITY

163 SR No 01300301

Item Dinoprostone vaginal tablet3mg 25,068 Tabs

Specification Dinoprostone Vaginal Tablet, 3mg

Each tablet to contain 3mg of Dinoprostone BP/USP for vaginal use

Note:


164 SR No 00103901

Item Trimethoprim Tab. 100mg 9,813 Tabs

Specification Trimethoprim Tablets BP, 100mg

Each tablet to contain 100mg of Trimethoprim BP

Tablet should also conform to disslution test as for USP

OR

Trimethoprim Tablets USP, 100mg

Each tablet to contain 100mg of Trimethoprim USP165 SR No 00404002

Item Epoetin Inj.4000IU-5000IUPF.Syr 316,578 PF.Syrs

Specification Epoetin injection 4,000IU-5,000IU prefilled syringe

Each pre-filled syringe to contain 4,000IU to 5000IU of Epoetin

(Recombinant

Human Erythropoietin) in water for injection BP/USP for

subcutaneous or

intravenous injection.

Note:

1. The product should be stable for minimum of 02 years when

stored under

2'C-8'C.

2. Each Pre-filled syringe should be labeled accordingly.166 SR No 00101404

Item Cefuroxime Syr.125mg/5ml,100ml bot. 13,425 Bots

Specification Cefuroxime axetil oral suspension 125mg/5ml in 100ml bottle

Cefuroxime axetil for oral suspension USP 125mg / 5ml

OR

Cefuroxime axetil for oral suspension 125mg / 5ml

Each bottle to contain Cefuroxime axetil BP/USP as dry, free flowing

powder

with one or more suitable buffers, colours, diluents, dispersants and

flavoured

vehicle for reconstitution with water before use to give final volume

of

reconstitued preparation to be 100ml. The reconstitued preperation

to contain

125mg of Cefuroxime axetil BP/USP in 5ml

Note:


WHO.

2.The bottle should be embossed at 100ml level

3.Oversize bottle should be provided to facilitate

reconstitution.

4.The product should be stable for a minimum of 24

months when stored at a temperature range of 28'C-32'C167 SR No 01104801

Item Zinc oxide powder 126,624 gs

Page No 33 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Zinc oxide BP/USP, (Extra fine powder)

Pack: 500g in well closed container

Note:


168 SR No 00201701

Item Hydralazine HCl Tab. 50mg 18,237 Tabs

Specification Hydralazine tablet BP 50mg

Each tablet to contain 50 mg of Hydralazine Hydrochloride BP

Tablet should also confirm to dissolution test for Hydralazine

Hydrochloride

tablet as per USP.

OR

Hydralazine Hydrochloride tablet USP 50mg

Each tablet to contain 50mg of Hydralazine Hydrochloride USP.

Note:


169 SR No 00802601

Item Sodium Biphosphate 1.6g+Sodiumphosp. 0.6g enema in10ml,120ml 31,233 Bots

Specification Sodium Biphosphate 1.6g and Sodium phosphate 0.6g enema in

10ml, 120ml container

Each 10ml to contain 1.6g of Sodium Biphosphate and 0.6g of

Sodium Phosphate

Note:

01.Each container should consist of one way safety vale, lubricated

tip and protective cap


03. Each bottle should be labelled accordingly

170 SR No 00405301

Item Albumin Solution (human)20%,50ml 84,354 Bots

Specification Human albumin solution BP /Ph Eur, 20% in 50ml bottle

Each 50ml vial to contain at least 95% of the Albumin Protein BP / Ph

Eur,

derived from human plasma serum.

Note:


as

recommended by WHO.

2.The product should be stable for minimum of 02 years when stored

under the

storage condition stipulated by the manufacturer.



5.The manufacturer should submit a certificate for each batch of the

product

that it has been tested free of Hepatitis B, Hepatitis C, and HIV

infections"171 SR No 00306702

Item Quetiapine modified releasetablet 200mg 119,889 Tabs

Specification Quetiapine Modified Release tablets 200mg

Each prolonged-release tablet to contains 200mg of Quetiapine

Note :


172 SR No 00103003

Page No 34 of 89




NO OF ITEMS 418


ITEM QUANTITY

Item Clarithromycin syr.125mg/5ml,100ml 18,099 Bots

Specification Clarithromycin for oral suspension USP, 125mg/5ml in 100ml bottle

Each bottle to contain dry free flowing powder/granules of

Clarithromycin with

one or more suitable buffers, colours, diluents, dispersing agents,

preservatives and flavoured vehicle for reconstitution with water

before use, to

give final volume of reconstituted preparation to be 100ml.

The reconstituted preparation to contain 125mg of Clarithromycin in

5ml.

Note:

1. The bottle should be embossed at 100ml level.

2. Oversize bottle should be provided to facilitate reconstitution.


173 SR No 01206101

Item Filgrastim injection300mcg in 0.5ml /1ml PFS/vial 53,784 Vials

Specification Filgrastim Injection 300mcg in 0.5ml/1ml.

Each Pre-filled syringe / vial to contain 300mcg of Filgrastim for

subcutaneous

injection or intravenous infusion.

Note:

1.Shelf life of the product should be minimum of 24 months

2.Each pre-filled syringe/vial should be labelled accordingly.

174 SR No 00000301

Item Fentanyl Injection100microgram in 2ml 190,107 Amps

Specification Fentanyl Citrate Injection USP 100mcg in 2ml Ampoule.

Each amber coloured glass Ampoule to contain 100mcg/2ml of

Fentanyl Citrate in

water for injection for intravenous infusion,spinal and epidural use.

Note;




3.Ampoule should be scored.

175 SR No 00302001

Item Risperidone Tab.2mg 7,757,574 Tabs

Specification Risperidone tablet 2mg

Each coated tablet to contain 2mg of Risperidone BP/USP

Note:


176 SR No 00300803

Item Haloperidol Inj. 5mg/1ml 24,357 Amps

Page No 35 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Haloperidol Injection BP 5mg/1ml

Each 1ml amber coloured ampoule to contain 5mg of Haloperidol BP

for

intramuscular injection

OR

Haloperidol injection USP 5mg/1ml

Each 1ml amber coloured ampoule to contain 5mg of Haloperidol

USP for

intramuscular injection

Note:

1.The Injection should be stable for minimum of 24


2. Each ampoule should be labelled accordingly177 SR No 00701703

Item Prednisolone Tablet 20mg 324,126 Tabs

Specification Prednisolone Tablet BP/USP, 20mg

Each tablet to contain 20mg of Prednisolone BP/USP.

Note:


178 SR No 00501802

Item spacer device for compatiblewith all metered dose inhalers 31,311 Devices

Specification Spacer device for compatible with all metered dose inhalers

Each spacer device should be compatible with all metered dose

inhalers.

179 SR No 01301801

Item Tolterodine tablet 1mg 17,343 Tabs

Specification Tolterodine tablet 1mg

Each tablet to contain 1mg of Tolterodine

Note:


180 SR No 00701603

Item Dexamethasone Tablet 4 mg 78,600 Tabs

Specification Dexamethazone Tablets BP 4mg

Each tablet to contain 4mg of Dexamethazone BP

Tablet should also conformed to dissolution test for Dexamethazone

Tablets as per USP

OR

Dexamethazone Tablets USP 4mg

Each tablet to contain 4mg of Dexamethazone USP

Note:



181 SR No 00400701

Item Potassium Chloride Tab. 600mg 3,161,880 Tabs

Specification Slow Potassium Chloride tablets BP 600mg.

OR

Potassium Chloride extended release tablets USP 600mg.

Each coated tablet to contain 600mg of Potassium Chloride (8mmol

of Potassium

and of Chloride) BP/USP in a slow release form.

Note:


182 SR No 00304004

Page No 36 of 89




NO OF ITEMS 418


ITEM QUANTITY

Item Sodium valproate syrup200mg/5ml,100ml 18,171 Bots

Specification Sodium Valproate Oral Solution BP, 200mg/5ml, 100ml bottle Each

bottle to contain 200mg / 5ml of Sodium Valproate BP

in a suitable flavoured vehicle.

Note:


183 SR No 00303801

Item Carbamazepine tablet 100mg 642,924 Tabs

Specification Carbamazepine Tablets BP 100mg.

Each tablet to contain 100mg of Carbamazepine BP.

Tablet should also conformed to dissolution test for Carbamazepine

Tablet as per USP

OR

Carbamazepine Tablets USP 100mg.

Each tablet to contain 100mg of Carbamazepine USP.

Note:

01.The tender should provide a detailed bio-equivalent data


184 SR No 00205201

Item Protamine sulphate inj50mg/5ml 3,795 Vials

Specification Protamine Sulphate injection BP 50mg/5ml.

Each 5ml ampoule to contain 50mg of Protamine Sulphate BP in

water for injection BP/USP for intravenous injection

OR

Protamine Sulfate injection USP 50mg/5ml

Each 5ml ampoule to contain 50mg of Protamine Sulphate USP in

water for injection BP/USP for intravenous injection

OR

Protamine Sulfate for injection USP 50mg/5ml.

Each 5ml ampoule to contain 50mg of Protamine Sulfate USP as

sterile dry powder with suitable dry diluents for

reconstitution with suitable solvent before use for intravenous

injection.

Note:


months when stored within the temperature range of

2C - 8C.

2.Sufficient overage to be added to the adequate shelf

life.


Item Co-amoxiclav Tab. 375mg 3,837,456 Tabs

Specification Co-Amoxiclav Tablet BP 375mg.

Each tablet to contain Amoxicillin Trihydrate BP equivalent to 250mg

of

Amoxicilln and 125mg of Potassium Clavulanate BP.

Note:

01.Tablet should conform to bio equivalence criteria Of the WHO


186 SR No 01203602

Item Carboplatin inj. 450mg/45mlvial 8,643 Vials

Page No 37 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Carboplatin Injection BP,450mg

Each 45ml vial to contain 450mg of Carboplatin BP in water for

injection BP/USP

for intravenous use.

Note:


months when stored under manufacturer's conditions.

2.Each vial should be labeled accordingly187 SR No 00301902

Item Olanzapine Tab.10mg 4,996,677 Tabs

Specification Olanzapine tablet 10mg

Each coated tablet to contain 10mg of Olanzapine

Note:


188 SR No 00603205

Item Human immunoglobulin for IVuse 5-6g 24,468 Vials

Specification Normal immunoglobulin for intravenous use BP,5g - 6g Vial.

Each vial to contain 5g - 6g of liquid or freeze-dried preparation of

Normal

Immunoglobulin BP for intravenous use.

The immunoglobulin should be mainly immunoglobulin IgG and

contain only trace

amount of IgA.

Note:

1.This product should be stable for 02 years when stored under

storage condition

stipulated by the manufacturer.

2.Tenderers should submit detail specification of the product offered

by them.


as

recommended by WHO.

4.The product should be certified as free from HIV and hepatitis

virus.


Item Prednisolone Tablet 1mg 189,756 Tabs

Specification Prednisolone Tablet BP/USP, 1mg

Each tablet to contain 1mg of Prednisolone BP/USP.

Note:


190 SR No 01103901

Item Sodium chloride Crystals 1,109,871 gs

Specification Sodium Chloride BP/USP, (Crystals)

Pack; 500g in a well closed container

Note:


191 SR No 00400306

Item Iron syrup 50mg/5ml,100ml bottle 39,600 Bots

Specification Iron syrup 50mg/5ml, 100ml bottle

Each 5ml to contain 50mg of elemental iron in suitable

syrup/suspension base

Note:


192 SR No 00901302

Item Cyclopentolate Eye Drops1.0%,5ml 3,873 Vials

Page No 38 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Cyclopentolate Eye drops BP

OR

Cyclopentolate Hydrochloride Ophthalmic solution USP

Each 5ml dropper bottle to contain 1% w/v sterile solution of

Cyclopentolate

hydrochloride BP/USP in purified water.

Note:

1. The tamper evident dropper bottle should assure the sterility of

the product.

2. The product should be stable for a minimum of 02 years when


3. Each bottle should be labelled accordingly.193 SR No 00302701

Item Fluoxetine hydrochloride Cap.20mg 4,754,574 Caps

Specification Fluoxetine Hydrochloride Capsule BP,20mg

Each capsule to contain 20mg of Fluoxetine Hydrochloride BP

Note:


194 SR No 00103501

Item Vancomycin Inj. 500mg vial 71,655 Vials

Specification Vancomycin Hydrochloride Injection 500mg Vial

Vancomycin Hydrochloride for injection USP, 500mg

Each 10ml vial to contain 500mg of Vancomycin Hydrochloride USP

as sterile dry

powder for reconstitution with water for injection BP/USP, before

use for

intravenous infusion.

OR

Vancomycin injection BP, 500mg

Each 10ml vial to contain 500mg of Vancomycin Hydrochloride BP as

sterile dry

powder for reconstitution with water for injection BP/USP, for

intravenous

infusion.

Note:


years when stored below 25'C


Item Mycophenolate mofetil cap.500mg 1,163,526 Caps

Specification Mycophenolate Mofetil Capsule 500mg

Each capsule to contain 500mg of Mycophenolate Mofetil

OR

Mycophenolate Mofetil Tablet 500mg (SR126034)

Each tablet to contain 500mg of Mycophenolate Mofetil

Note:


196 SR No 01000801

Item Ofloxacin ear drops 0.6%, 5ml 1,332 Vials

Page No 39 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Ofloxacin ear drops 0.6% 5ml dropper bottle

Each 5ml dropper bottle to contain 0.6% of Ofloxacin for ear drops.



2.Product should be stable for minimum of 24 months when stored


3.Each bottle should be labelled accordingly.

197 SR No 00400901

Item Sodium bicarbonate tablet600mg 4,199,610 Tabs

Specification Sodium Bicarbonate tablets USP, 600mg

Or

Compound Sodium Bicarbonate Tablets BP, 600 mg

Each tablet to contain 600mg of Sodium Bicarbonate with a suitable

flavor.

Note :

01.The product should be preserved in well-closed containers


198 SR No 01202701

Item Etoposide capsule 100mg 1,809 Caps

Specification Etoposide Capsules USP 100mg

Each capsule to contain 100mg of Etoposide USP.

Note:


199 SR No 01201401

Item Mitomycin injection 2mg vial 5,631 Vials

Specification Mitomycin for injection USP/JP 2mg vial

Each vial to contain a mixture of 2mg of Mytomycin USP/JP and

Mannitol USP as

sterile dry powder for reconstitution before intravenous use

Note:


months when stored at a temperature range of 28'C - 32'C


Item Salicylic acid powder 225,867 gs

Specification Salicylic Acid BP/USP (Fine Powder)


Note:


201 SR No 00904003

Item Chloramphenicol Eye Oint..1%,3.5g Tube 22,062 Tubes

Specification Chloramphenicol Eye Ointment BP 1%,

OR

Chloramphenicol ophthalmic ointment USP 1%

Each 3.5g sealed temper-evident, collapsible tube to contain 1% of

Chloramphenicol BP/USP in a suitable eye ointment base.

Note:



2.Tube should be designed with suitable nozzle to

deliver eye ointment, in printed cartons.

3.Each tube should be labelled accordingly.

202 SR No 00402802

Item Pyridoxine HCl Tab. 25mg 658,425 Tabs

Page No 40 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Pyridoxine Tablets BP 25mg.

Each tablet to contain 25mg of Pyridoxine Hydrochloride BP Tablet

should also conform to dissolution test for

Pyridoxine Hydrochloride tablet as per USP.

OR



Note:

01.Sufficient overage to be added to ensure the the adequate shelf

life


203 SR No 01600201

Item Acetylcysteine injection2g/10ml amp 39,759 Amps

Specification Acetylcysteine Injection BP 2g/ 10ml

Each 10ml amber colourd ampoule to contain 2g of Acetylcysteine

BP for

intravenous injection/infusion.

Note:

1.This injection should be stabled for a minimum of 24


2. To be protected from light


Item Bupivacaine inj. 0.5%/10ml with st.wrap 73,950 Amps

Specification Bupivacaine Injection BP 0.5%, 10ml

Each 10ml ampoule to contain Bupivacaine Hydrochloride BP

equivalent to 0.5% w/v

of anhydrous Bupivacaine Hydrochloride in a pre-sterilized theatre

pack,suitable

for epidural injection and local infiltration.(The product should be

preservative free)

OR

Bupivacaine Hydrochloride Injection BP 0.5%, 10ml

Each 10ml ampoule to contain Bupivacaine Hydrochloride USP

equivalent to 0.5%

w/v of anhydrous Bupivacaine Hydrochloride in a pre-sterilized

theatre

pack,suitable for epidural injection and local infiltration.(The product

should

be preservative free)

Note:


months when stored under at a temperature range of 28'C-32'C

2.This injection should comply with the No.15.4(d)

labelling for anaesthetic products of tender

documents.


205 SR No 00205903

Item Tranexamic acid Inj.500mg 152,916 Amps

Specification Tranexamic acid injection BP 500mg in 5ml.

Each 5ml ampoule to contain 500mg of Tranexamic Acid BP in water

for injection

BP/USP for slow intravnous injection.

Note:

1.This injection should be stable for a minimum of



Page No 41 of 89




NO OF ITEMS 418


ITEM QUANTITY

Item Mercaptopurine tablet 50mg 35,439 Tabs

Specification Mercaptopurine Tablets BP/USP 50mg

Each tablet to contain 50mg of Mercaptopurine BP/USP

Note:


207 SR No 00205901

Item Tranexamic acid cap. 500mg 771,099 Caps

Specification Tranexamic Acid Capsule 500mg.

Each capsule to contain 500mg of Tranexamic Acid BP.

Note:


208 SR No 00404001

Item Epoetin inj. 2000 IU PF.Syr 60,876 PF.Syrs

Specification Epoetin injection 2,000 IU Pre-filled syringe

Each pre-filled syringe to contain 2,000 IU of Epoetin (Recombinant

Human

Erythropoietin) in water for injection BP/USP for subcutaneous or

intravenous

injection.

Note:

1. The product should be stable for minimum of 02 years when

stored under

2'C-8'C.

2. Each Pre-filled syringe should be labeled accordingly.209 SR No 01502301

Item Lignocaine with Prilocaine cream 5g tube 9,366 Tubes

Specification Lignocaine 2.5%w/w with Prilocaine 2.5%w/w, 5g Tube

Each 5g collapsible tube to contain Lidocaine BP/USP 2.5%w/w and

Prilocaine

BP/USP 2.5% w/w in a suitable cream base for topical anaesthesia.

Note:

1. This product should be stable for a minimum of 24 months at a

temperature range of 28'C-32'C

2. Each collapsible tube should be labelled accoprdingly.

3.This product should be supplied together with occlusive dressing.

Pack: 5g in air tight sealed printed collapsible tubes, in printed

cartons.

210 SR No 00105801

Item Levofloxacin Tab. 500mg 78,627 Tabs

Specification Levofloxacin 500mg tablet

Each tablet to contain 500mg of Levofloxacin.

Note:


211 SR No 01200304

Item Cyclophosphamide Inj. 1 g vial 6,867 Vials

Page No 42 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Cyclophosphamide for injection BP, 1g

Each vial to contain Cyclophosphamide BP equivalent to 1g of

anhydrous Cyclophosphamide as sterile, dry powder for

reconstituiton

with water for injection BP/USP before use, for intravenous injection.

OR

Cyclophosphamide for injection USP,1g

Each vial to contain Cyclophosphamide USP equivalent to 1g of

anhydrous Cyclophosphamide as sterile, dry powder for

reconstituiton

with water for injection BP/USP before use, for intravenous injection.

Note;


stored a temperature range of 28'C-32'C


212 SR No 00206101

Item Dried,Factor VIII fraction200-350 IU vial 23,973 Vials

Specification Dried factor VIII Fraction BP (Dried Human Antihaemophilic Fraction)

OR

Human Coagulation Factor VIII Ph Eur. OR Antihemophilic Factor

USP OR Dried Human Antihaemophilic Fraction IP

Each vial to contain 200 - 350 IU of concentrated, monoclonal

purified and detergent treated dried factor VIII Fraction

BP,Ph Eur,USP or IP.

Note:

1. The item should be stable at temperature 2'C - 8'C.

2. The product should have minimum 24 months shelf life at the time

of delivery to MSD.

3. Tenderer should submit detailed specifications of the product

offered.

4. The product should ensure, at least two steps on virus inactivation

as recommended by WHO/US.FDA

5. The donor selection process should be specified by the

manufacturer.

6. Each batch should be certified as free from HIV and hepatitis

viruses.

7. Anti viral test methods used for screening for HIV and Hepatitis

viruses should be declared by the manufacturer. The

test methods used should be approved by WHO/US.FDA.

8. Each vial to be supplied with suitable diluent.

9. The product should be protected from light.213 SR No 00402202

Item Amino acids Solu. 500ml 4,497 Bots

Page No 43 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Protein Hydrolysate injection USP 10% w/v in 500ml Bottle.

Each 100ml solution to contain Amino Acids and short chain peptides

which

represents the approximate nutritive equivalent to the casein,

Lactalbumin,plasma fibrin or other suitable protein which derived by

the acid,

encymatic or other methods of hydrolysis.It may contain alcohol,

Dextrose or

other carbohydrate suitable for intravenous infusion not less than

50% of the

total nitrogen present is in the form of L-amino Nitrogen for

intravenous

infusion.

Note:

1. The bottle should be graduated to 500ml and be made of

medicinal grade

Polyethylene or Polypropylene. PVC is not acceptable.

2. The bottle should have a device for hanging.


continuous use the site of the insertion of piercing spike should be

covered

with a sterile rubber disk or bung and the plastic cover of the disk or

bung

should be fused to neck of the bottle right round.

4. Each bottle should be packed individually in a protective

polyethylene cover.214 SR No 01206802

Item Tamoxifen tablet 20mg 551,922 Tabs

Specification Tamoxifen tablets BP 20mg

Each tablet to contain Tamoxifen Citrate BP equivalent to 20mg of

Tamoxifen.

Tablet should also conform to dissolution test for Tamoxifen Citrate

tablets as

per USP

OR

Tamoxifen Citrate tablets USP 20mg

Each tablet to contain Tamoxifen Citrate USP equivalent to 20mg of

Tamoxifen

Packing: Pack suitably to ensure to protect from light until the time

of

administration of the drug

Pack size: 100 tablets in a pack.

Note:


215 SR No 01205403


Specification Cyclosporin Capsule USP 100mg

Each capsule to contain 100mg of Cyclosporin USP

Note:


216 SR No 00204101

Item Isoprenaline HCl Inj.2mg/2ml 2,208 Amps

Page No 44 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Isoprenaline Injection BP 2mg/2ml

Each 2ml amber coloured ampoules to contain 2 mg of Isoprenaline

Hydrochloride

BP for intravenous infusion.

OR

Isoproterenol Hydrochloride injection USP 2mg/2ml

Each 2ml amber coloured ampoule to contain 2mg of Isoproterenol

Hydrochloride

USP for intravenous infusion.

Note:

1.The injection should be stable for a minimun of 24



Item Protein hydrolysate Inj. 100ml 2,700 Bots

Specification Protein Hydrolysate injection USP in 100ml Bottle.

Each 100ml solution to contain Amino Acids and short chain peptides

which

represents the approximate nutritive equivalent to the casein,

Lactalbumin,

plasma fibrin or other suitable protein which derived by the acid,

enzymatic or

other methods of hydrolysis. It may contain alcohol, Dextrose or

other

carbohydrate suitable for intravenous infusion not less than 50% of

the total

nitrogen present is in the form of L-amino Nitrogen for intravenous

infusion for

infants and children.

Note:


medicinal grade

Polyethylene or Polypropylene. PVC is not acceptable.



continuous use the site of the insertion of piercing spike should be

covered

with a sterile rubber disk or bung and the plastic cover of the disk or

bung

should be fused to neck of the bottle right round.218 SR No 00400702

Item Potassium Chloride 15%, Inj.10ml 100,953 Amps

Specification Sterile Potassium Chloride concentrate BP, 15% w/v/10ml

OR

Potassium Chloride for injection concentrate USP 15% w/v/10ml

Each 10ml ampoule to contain 15% w/v of Potassium Chloride

BP/USP for

intravenous use.

Note:

1. This injection should be stable for a minimum of 24 months when



219 SR No 00108203

Item Oseltamivir Cap. 75mg 107,775 Caps

Specification Oseltamivir Phosphate Capsule 75mg

Each capsule to contain 75mg of Oseltamivir Phosphate.

Note:


Page No 45 of 89




NO OF ITEMS 418


ITEM QUANTITY

220 SR No 01300701

Item Sodium citrate powder 159,975 gs

Specification Sodium citrate BP,(in powder form)

Each gram to contain Sodium citrate BP,(in powder form)

Note:


221 SR No 00107901

Item Aciclovir Tab. 200mg 1,110,774 Tabs

Specification Acyclovir tablet USP 200mg

Each tablet to contain 200mg of Acyclovir USP

OR

Aciclovir tablet BP 200mg

Each tablet to contain 200mg of Aciclovir BP.

Note:


222 SR No 00502001

Item Baby mask for Spacer device 6,411 Devices

Specification Plastic,mask to compatible with spacer device

223 SR No 00401004

Item Sodium chloride for IV use,3%,500ml 23,436 Bots

Specification Sodium Chloride intravenous infusion BP 3 % w/v

OR

Sodium Chloride injection USP, 3 % w/v

Each 500ml bottle to contain 3 % w/v of Sodium Chloride BP/USP in

water for injection BP/USP for intravenous infusion.

Note:


medicinal grade Polyethylene or Polypropylene. PVC is not

acceptable.



continuous use the site of the insertion of

piercing spike should be covered with a sterile rubber disk or bung

and the plastic cover of the disk or bung should

be fused to neck of the bottle right round.

4. Each bottle should be packed individually in a protective

polyethylene cover.

5. The product should be sterile and stable for a minimum of 24

months within a temperature range of 30 C- 35 C.

6. The bottle should be labelled accordingly.224 SR No 00603201

Item Human immunoglobulin for IVuse, 1g 4,878 Vials

Page No 46 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Normal immunoglobulin for intravenous use BP,1g Vial.

Each vial to contain 1g of liquid or freeze-dried preparation of

Normal

Immunoglobulin BP for intravenous use.

The immunoglobulin should be mainly immunoglobulin IgG and

contain only trace

amount of IgA.

Note:

1.This product should be stable for 02 years when stored under

storage condition

stipulated by the manufacturer.

2.Tenderers should submit detail specification of the product offered

by them.


as

recommended by WHO.

4.The product should be certified as free from HIV and hepatitis

virus.


Item Neostigmine injection2.5mg/1ml amp 54,072 Amps

Specification Neostigmine methyl sulphate Injection 2.5mg in 1ml Ampoule BP

OR

Neostigmine methyl sulphate Injection 2.5mg in 1ml Ampoule USP

Each 1ml amber coloured ampoule to contain 2.5mg of Neostigmine

Methyl Sulphate

BP or 2.5mg of Neostigmine Methyl Suphate USP for

Intramuscular,Intravenous or Subcutaneous injection.

Note:


stored


2.Each ampoule should be labelled accordigly.

226 SR No 01502105

Item Lignocaine anhydrous gel 2% ,30g tube 104,076 Tubes

Specification Lidocaine/Lignocaine gel BP, 2% w/v (Sterile)

Each air tight 30g tube to contain Lidocaine hydrochloride BP

equivalent to 2%

w/v of anhydrous Lidocaine hydrochloride in a suitable water soluble

sterile

viscous base.

OR

Lidocaine gelly USP, 2% w/v (Sterile)

Each air tight 30g tube to contain Lidocaine hydrochloride USP

equivalent to 2%

w/v of anhydrous Lidocaine hydrochloride in a suitable water soluble

sterile

viscous base.

Note:



2.Each tube should be labelled accordingly.227 SR No 00501304

Item Chlorpheniramine maleateInj.10mg/1ml 91,515 Amps

Page No 47 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Chlorpheniramine/Chlorphenamine injection BP 10mg/ml

Each 1ml to contain 10mg of Chlorpheniramine Maleate/

Chlorphenamine Maleate BP

in water for injection BP/USP for subcutaneous, intramuscular and

intravenous

use

OR

Chlorpheniramine Maleate injection USP

Each 1ml to contain 10mg of Chlorpheniramine Maleate USP in water

for injection

BP/USP for subcutaneous, intramuscular and intravenous use

Note:



2.Each ampoule should be labelled accordingly228 SR No 00702801

Item Clomiphene citrate tablet 50mg 63,636 Tabs

Specification Clomifene tablets BP 50mg.

Each tablet to contain 50mg of Clomiphene Citrate BP

OR

Clomifene tablets USP 50mg.

Each tablet to contain 50mg of Clomiphene.

Note:


229 SR No 00703502

Item Alendronate sodium tablet 70mg 190,515 Tabs

Specification Alendronate sodium tablet 70mg

Each tablet to contain Alendronate Sodium USP equivalent to 70mg

of Alendronic

Acid.

OR

Sodium Alendronate tablet 70mg

Each tablet to contain Sodium Alendronate BP equivalent to 70mg of

Alendronic

Acid.

Note:


230 SR No 01200301

Item Cyclophosphamide tablet 50mg 74,775 Tabs

Specification Cyclophosphamide tablets BP/USP 50mg

Each coated tablet to contain Cyclophosphamide BP equivalent of

50mg of anhydrous Cyclophosphamide.

Note:

1.The tablet should be stable for a minimum of 24 months when

stored at a temperature range of 28'C -32'C.231 SR No 00000802

Item Morphine sulphate Tab. 15mg 76,569 Tabs

Specification Morphine Tablet BP 15mg.

Each Tablet to contain 15mg of Morphine sulphate BP.

Note:


232 SR No 00101601

Item Ceftazidime Inj. 500mg 61,230 Vials

Page No 48 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Ceftazidime Injection 500mg vial

Each vial to contain Ceftazidime Pentahydrate equivalent to 500mg

of Ceftazidime

USP as a sterile dry powder for reconstitution with suitable diluent

for

intramuscular and intravenous use

Note:


WHO.


years when stored at a temperature not exceeding

25'C.


Item Miconazole Oromucosal gel 40gTube / Container 8,397 Tubes

Specification Miconazole Oromucosal gel BP 40g tube.

Each 40g tube to contain 20mg/g of Miconazole BP as a very fine

powder suspended

in water miscible basis and may be flavoured.

The preparation should be sugar free.

Note:

1. The product should be suitable for minimum of 2 years protect

from light.

2. Each tube / container should be labelled accordingly.

Pack: 40g sealed printed tube/container, printed cartons.234 SR No 00303201

Item Aspirin Tab. 300mg 2,232,939 Tabs

Specification Aspirin Tablets BP 300mg

Each Tablet to contain 300mg of Aspirin BP

OR

Aspirin Tablets USP 300mg

Each Tablet to contain 300mg of Aspirin USP

Note:


235 SR No 00100906

Item Co-Amoxiclav dispersibletablet 125mg 106,500 Tabs

Specification Co-Amoxiclav dispersible tablets BP 125mg

Each dispersible Co-amoxiclav tablet to contain Amoxicillin

Trihydrate BP

equivalent to 125mg of Amoxicilln and 31.25mg of Potassium

Clavulanate BP

Note:

01.The product should conform to bio equivalence criteria of the

WHO


236 SR No 00304401

Item Lamotrigine Tab 25mg 923,262 Tabs

Specification Lamotrigine tablet 25mg

Each tablet to contain Lamotrigine 25mg

Note:


237 SR No 00901001

Item Prednisolone acetate Eye Drop1%,5ml 107,481 Vials

Page No 49 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Prednisolone Acetate Ophthalmic Suspension USP w/v

Each 5ml dropper bottle to contain 1% w/v of sterile suspension of

Prednisolone Acetate USP in a suitable vehicle.

Note:

1. The container should be sealed tamper - evident to assure the

sterility of the product

2. Should be protected from light.

3. Product should be stable for minimum of 24 months when stored


4. Each bottle should be labelled accordingly238 SR No 01400306

Item Diclofenac sodium Supp.100mg 275,700 Supps

Specification Diclofenac Sodium suppository 100mg

Each suppository to contain 100mg of Diclofenac Sodium BP/USP in a

suitable

suppository base.

Note:


when stored

at a temperature bellow 30'C.


Item Calcium gluconate 10%, Inj.10ml 106,860 Amps

Specification Calcium Gluconate injection BP/USP, 10% w/v

Each 10ml glass ampoule to contain Calcium Gluconate BP/USP

equivalent to 10%

w/v of anhydrous Calcium Gluconate in water for injection BP/USP

for

Intravenous, Intramuscular and intra - cardiac use.

Note:



2.The preparation should be sterilized with small

amount of suitable Calcium salt to prevent the

formation of solid particles.


Item Hydroxychloroquine sulph.Tab. 200mg 2,191,035 TABs

Specification Hydroxychloroquine sulphate tablet USP 200mg

Each tablet to contain 200mg of Hydroxychloroquine Sulphate USP

OR

Hydroxychloroquine tablets BP.

Each coated tablet to contain Hydroxychloroquine Sulphate BP

Note:


241 SR No 00701201

Item Carbimazole tablet 5mg 3,682,125 Tabs

Specification Carbimazole tablets BP 5mg

Each tablet to contain 5mg of Carbimazole BP.

Note:


242 SR No 01203702

Item Cisplatin injection 50mg vial 11,109 Vials

Page No 50 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Cisplatin injection BP, 50mg/50ml

Each 50ml vial to contain 50mg of Cisplatin BP in water for injection

BP/USP

for intravenous injection.

OR

Cisplatin for injection BP/USP, 50mg

Each vial to contain 50mg Cisplatin BP/USP as sterile dry powder for

reconstitution with water for injection BP/USP, before use for

intravenous

injection

Note:


months when stored under temperature range of

15 C - 30 C, Protect from light.


243 SR No 01207301

Item Goserelin acetate implant3.6mg 3,558 Implnts

Specification Goserelin Acetate 3.6mg implant in syringe applicator.

Each implant to contain Goseraline Acetate Ph Eur 3.6mg for

subcutaneous use.

Note;

1.The product should be stable for a minimum of 24 months

when stored below 25'C .


3.Each implant should be labelled accordingly.244 SR No 01101501

Item Hydrocort 0.5% + Clioquinol3% Cream 15g 52,530 Tubes

Specification Hydrocortisone and Clioquinol Cream, BP

Each 15g collapsible tube to contain 0.5% w/w of Hydrocortisone BP

and 3.0% w/w

of Clioquinol BP in a suitable cream base

OR

Clioquinol and Hydrocortisone Cream USP

Each 15g collapsible tube to contain 0.5% w/w of Hydrocortisone USP

and 3.0% w/w

of Clioquinol USP in a suitable cream base

Note:





cartons245 SR No 00402702

Item Thiamine HCl Inj. 100mg/2ml 66,495 Amps

Specification Thiamine Hydrochloride Injection BP 100mg/2ml

OR

Thiamine Hydrochloride USP 100mg/2ml

Each 2ml ampoule to contain 100mg of Thiamine Hydrochloride

BP/USP intravenous

use.

Note:

1.The injection should be stable for a minimum of 24

months when storedat a temperature range of 28'C-32'C.


Item Glyceryl trinitrate Inj.50mg/10ml 18,303 Vials

Page No 51 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Nitroglycerin Injection USP 50mg/10ml

Each 10ml vial/ampoule to contain 50mg of Nitroglycerin for

preparing Intravenous

infusion.

Note:



2.Each vial/ampoule should be labelled accordingly.247 SR No 01500701

Item Sevoflurane 250ml bottle 3,309 Bots

Specification Sevoflurane for anaesthetic inhalation 200ml - 300ml bottle

Each 200ml - 300ml unbreakable bottle to contain Sevoflurane for

anaesthetic

inhalation

Note:

1. The bottle should be light resistant.

2. If the bottle is not an unbreakable one, action to be taken in case

of

breakage of the bottle, should be clearly mentioned on the label

affixed.

3. If the bottle has no inbuilt adapter, the successful bidder should

provide

one adapter per each ten bottle free of charge.


248 SR No 00500704

Item Beclometasone arosolInh.50mcg/MDI,200d 8,229 Inhals

Specification Beclomethasone Dipropionate aerosol Inhaler 50mcg/metered dose,

200 dose unit


suitable propellants

to contain suspension of Beclomethasone Dipropionate BP to deliver

50mcg of

Beclomethasone Dipripionate per metered inhalation.

Note :

1. Each non-reactive aerosol container equipped with metered dose

valve,to be


2. Tenderers should give detail specifications of the product offered

along with

samples.249 SR No 00201103

Item Propranolol Inj.1mg/1ml 186 Amps

Specification Propranolol injection BP 1mg in 1ml.

Each 1ml ampoule to contain 1mg of Propranolol Hydrochloride BP

for slow


OR

Propranolol injection USP 1mg in 1ml.

Each 1ml ampoule to contain 1mg of Propranolol Hydrochloride USP

for slow


Note:




Item Nystatin Tab. 500,000 I.U. 195,141 Tabs

Page No 52 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Nystatin Tablet BP 500,000 IU.

Each coated tablet to contain 500,000 IU of Nystatin BP for oral use.

OR

Nystatin Tablet USP 500,000 IU.

Each coated tablet to contain 500,000 IU of Nystatin USP for oral use.

Note:

1. Should be packed in air-tight containers.

2. The tablet should be stable for a minimum of 24

months when stored under the prescribed temperature.

251 SR No 00000402

Item Fentanyl transdermal patches12mcg per hour 1,140 Patchs

Specification Fentanyl Citrate transdermal self adhesive patches 12mcg/h,

Each self adhesive transdermal patch to contain Fentanyl Citrate in a

suitable matrix or reservoir presentation.

The content should be released at a constant rate of 12mcg/h for 72

hours.

Note:

1. This transdermal patches should be stable for minimum of 24


2. Each patch to be labelled accordingly252 SR No 00001301

Item Alfentanil Hydrocloride Inj.1000microgram / 2ml 759 Amps

Specification Alfentanil Injection USP 1000mcg in 2ml ampoule.

Each ampoule to contain 1000mcg/2ml of Alfentanil Hydrochloride in

water for

injection for intravenous use.

Note;




3.Ampoule should be scored.253 SR No 00101102

Item Sulbactam/Cefoperazone Inj.2g vial 10,809 Vials

Specification Sulbactam sodium and Cefoperazone sodium injection(1:1) 2g vial.

Each vial to contain Sulbactam sodium BP/USP equivalant to 1g of

Sulbactam and Cefoperazone sodium BP/USP equivalant to 1g of

Cefoperazone as a sterile dry powder for reconstitution with

suitable diluent for intramuscular or intravenous use.

Note:


WHO.

02.The product should be stable for 02 years when stored at a

temperature range of 28'C-32'C.


254 SR No 00101401

Item Cefuroxime Tab. 125mg 655,113 Tabs

Page No 53 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Cefuroxime Axetil tablet USP, 125mg

Each film coated tablet to contain Cefuroxime Axetil USP, Equivalent

to 125 mg

of Cefuroxime.

OR

Cefuroxime Axetil tablet BP, 125mg

Each film coated tablet to contain Cefuroxime Axetil BP, Equivalent

to 125mg of

Cefuroxime.

Note:

01.The product should conform to bio equivalence criteria of the

WHO


255 SR No 00101901

Item Cefepime Inj. 500mg vial 2,154 Vials

Specification Cefepime for injection USP, 500mg

Each vial to contain sterile Cefepime for injection USP equivalent to

500mg of

Cefepime as sterile dry powder for reconstitution with water for

injection

BP/USP for Intravenous injection.

Note:


WHO.

02. The product should be stable for a minimum of two years when

stored at a

temperature range of 25 C-30 C

03. Each vial should be labeled accordingly.256 SR No 00304801

Item Vigabatrin Tab. 500mg 63,393 Tabs

Specification Vigabatrin 500mg Tablets

Each tablet to contain 500mg of Vigabatrin

Note:


257 SR No 00306703

Item Quetiapine tablet 100mg 172,701 Tabs

Specification Quetiapine tablet 100mg

Each tablet to contain 100mg of Quetiapine

Note :


258 SR No 00501503

Item Adrenaline injection for selfadministration 45 PF.Syrs

Page No 54 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Adrenaline injection for self administration

Each 1.05ml single dose auto-injector devise to contain Adrenaline

Acid

Tartrate BP or Epinephrine BP/USP equivalent to

1 in 1,000 of Adrenaline/Epinephrine for subcutaneous,

intramuscular injection.

Note:



2.Should be protected from light.


Item Pancreatic enzyme capsule 96,492 Caps

Specification Pancreatic enzyme capsule (protease 600U, lipase 10000U, amylase

8000U)

Each capsule to contain pancreatin BP/USP containing enzymes,

principally 8000U of

amylase, 10,000U of lipase and 600U of protease, obtained from the

pancreas of

the hog, Sus scrofa Linne var. domesticus Gray (Fam. Suidae) or of

the ox, Bos

Taurus Linne var. Bovidae).

Note :

01.The product should be preserved in tight containers, at a

temperature not

exceeding 30'C


260 SR No 00802501

Item Terlipressin acetate inj.1mg vial 5,103 Vials

Specification Terlipressin acetate injection 1mg vial

Each vial to contain 1mg of Terlipressin acetate as sterile, dry powder

for reconstituiton and solvent for solution for

injection.

Note:


stored at a temperature below 25'C and

protected from light .


Item Povidone iodine cream 5%w/w,15g tube 42,381 Tubes

Specification Povidone Iodine cream 5% w/w (available iodine 0.5% w/w),

Each 15g collapsible tube to contain Povidone Iodine BP/USP 5% w/w

in a suitable cream base

Note:


stored at a temperature range of 28 ¿C- 32¿C

2. Each tube should be labeled accordingly with the indications for

use.

3. The supplier should provide NMRA registration and GMP

certification.

Pack: 15g in air tight, sealed, printed collapsible tube, in printed


Item Adapalene gel 0.1%,45g tube 16,320 Tubes

Page No 55 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Adapalenen gel BP 0.1%, w/w 45g in tube

Each 45g tube to contain 0.1%,w/w Adapalenen BP in a suitable

sterile viscous base for topical use.

Note:

1.The product should be stable for minimum of 24 months when





cartons.263 SR No 01202501

Item Vinblastine sulphateInjection 10mg vial 1,500 Vials

Specification Vinblastin Sulphate for injection BP, 10mg.

OR

Vinblastin Sulfate for injection USP, 10mg.

Each 10ml vial to contain Vinblastin Sulphate BP or Vinblastin Sulfate

USP

equivalent to 10mg of anhydrous Vinblastin Sulphate as sterile dry

powder for

reconstitution with 0.9% w/v of Sodium Chloride intravenous

infusion BP/ Sodium

Chloride injection USP for intravenous use.

OR

Vinblastin Sulphate injection BP, 10mg/10ml.

Each 10ml vial to conatin Vinblastin Sulphate BP equivalent to 10mg

of anhydrous

Vinblastin Sulphate in 0.9% w/v of Sodium Chloride intravenous

infusion BP as

ready to use solution for intravenous use.

Note:


24 months when stored under temperature range of 2'C - 8'C

Do not freeze


Item Mometasone Furoate 0.1%,15gtube 35,892 Tubes

Specification Mometasone Furoate Cream BP/USP 0.1%, 15g tube

Each 15 g of tube to contain 0.1% w/w of Mometasone Furoate

BP/USP in a suitable cream base.

OR

Mometasone Furoate Ointment BP/USP 0.1%, 15g tube

Each 15 g of tube to contain 0.1% w/w of mometasone furoate

BP/USP in a suitable ointment base.

Note:

01. The product should be stable for a minimum of 24 months when


02. Tube should be protected from light.


Pack: 15g in air tight, sealed, collapsible tubes, in printed cartons

265 SR No 00704001

Item Danazol cap. 100mg 48,834 Caps

Specification Danazole Capsule USP 100mg.

Each capsule to contain 100mg of Danazole USP.

Note:


266 SR No 01400701

Item Penicillamine Cap. 250mg 54,276 Caps

Page No 56 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Penicillamine tablets BP 250mg.

Each coated tablet to contain 250mg of Penicillamine BP

Tablet should also conform to dissolution test as per USP

OR

Penicillamine tablets/capsules USP 250mg.

Each capsule/tablet to contain 250mg of Penicillamine USP

Note:


267 SR No 00303304

Item Paracetamol Suppository 125mg 25,893 Supps

Specification Paracetamol suppositories BP 125mg.

Each suppository to contain 125mg of Paracetamol BP in a suitable

suppository basis.

OR

Acetaminophen suppositories USP 125mg.

Each suppository to contain 125mg of Acetaminophen USP in a

suitable suppository basis.

Note:

1.The product should be stable for 24 months when

stored at controlled room temperature(15'C- 25'C.)

2.Each suppository should be labelled accordingly268 SR No 00905201

Item Lidocaine HydrochlorideOphthalmic gel 2% in 30g tube 1,320 Tubes

Specification Lidocaine Hydrochloride Ophthalmic gel 2% in 30g tube

Each 30g tube contains Lidocaine Hydrochloride 2% in clear gel base

for ophthalmic use.

Note:


stored at temperature 32'C.


3.The tube should be designed with suitable nozzle to deliver

ophthalmic Jelly.269 SR No 00306101

Item Melatonin tablet 2mg 94,764 Tabs

Specification Melatonin tablets 2mg

Each tablet to contains 2mg of Melatonin

Note:


270 SR No 00103302

Item Chloramphenicol Inj.500mg Vial 5,853 Vials

Specification Chlormaphenicol Sodium Succinate for injection BP/USP 500mg

Each vial to contain Chloramphenicol Sodium Succinate BP/USP

equivalent to 500mg

of Chloramphenicol BP/USP

in water for injection BP/USP for intravenous injection

or infusion.

Note:

1.Product should conform to bio equivalence criteria of the WHO



3.Each vial should be labelled accordingly

271 SR No 00502501

Item Pirfenidone tablet 200mg 194,076 Tabs

Page No 57 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Pirfenidone tablets 200mg

Each coated tablet to contains 200mg of Pirfenidone

Note:


272 SR No 00800301

Item Mebeverine hydrochloridetablet 135mg 45,057 Tabs

Specification Mebeverine hydrochloride tablets BP 135mg

Each Coated tablet to contains 135mg of Mebeverine hydrochloride

BP

Note:


02.The product should be kept in an airtight container, protected

from light and stored at a temperature not exceeding 30'C.

273 SR No 00107302

Item Voriconazole Inj. 200mg in10ml 1,551 Vials

Specification Voriconazole injection 200mg in 10ml

Each 10ml vial to contain 200mg of Voriconazole for intravenous use

Note:


months when stored under stipulated storage condition



274 SR No 01105701

Item Mometasone furoate 0.1%,5gtube 17,586 Tubes

Specification Mometasone Furoate Cream BP/USP 0.1%,5g tube

Each 5 g of tube to contain 5 mg of Mometasone Furoate (0.1% w/w

Mometasone Furoate) BP/USP in a suitable cream base.

OR

Mometasone Furoate Ointment BP/USP 0.1%,5g tube

Each 5 g of tube to contain 5 mg of mometasone furoate (0.1% w/w

mometasone furoate) BP/USP in a suitable ointment base.

Note:



02. Tube should be protected from light.


Pack: 5g in air tight, sealed, collapsible tubes, in printed cartons

275 SR No 00107902

Item Aciclovir Tab. 800mg 346,299 Tabs

Specification Acyclovir tablet USP 800mg

Each tablet to contain 800mg of Acyclovir USP

OR

Aciclovir tablet BP 800mg

Each tablet to contain 800mg of Aciclovir BP.

Note:


276 SR No 01400301

Item Diclofenac sodium Tab. 25 mg 2,117,724 Tabs

Page No 58 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Diclofenac tablets BP

Each entric coated tablet to contain 25mg of Diclofenac Sodium BP

Note:


277 SR No 00702701

Item Testosterone enanthate Inj.250mg/1ml 3,330 Amps

Specification Testosterone enanthate Injection USP 250mg in 1ml Ampoule.

Each 1ml ampoule to contain 250mg of Testosterone enanthate USP

in suitable

vegiteble oil for slow intramuscular injection

Note:

1.The Injection should be stable for a minimum of 24 months when


2.Each ampoule should be labeled accordingly.278 SR No 00303305




suppository basis.

OR




Note:







suppository basis.

OR




Note:




Item Tinzaparin sodium Inj. 3,500units 2,652 PF.Syrs

Specification Tinzaparin sodium Injection 3,500 IU in 0.35ml prefilled syringe/vial

Each 0.35ml prefilled syringe or vial to contain 3,500 IU of Tinzaparin

Sodium

BP/Ph Eur, salt of a low molecular waight Heparin obtained by

depolimerization


Note;



manufacturer.

2.Each prefilled syringe/vial to be labelled accordingly.

281 SR No 01300601

Item Potassium citrate powder 127,749 gs

Page No 59 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Potassium Citrate BP/USP (As powder)

Each gram to contain Potassium Citrate BP/USP (As powder)

Note:


282 SR No 00403201

Item Phytomenadione Tab 5mg 23,403 Tabs

Specification Phytomenadione tablets BP 5 mg.

Each sugar coated tablet to contain 5 mg of Phytomenadione BP

OR

Phytomenadione tablets USP.

Each sugar coated tablet to contain 5 mg of Phytomenadione USP

Note:


283 SR No 00101405

Item Cefuroxime injection 250mgvial 79,911 Vials

Specification Cefuroxime Sodium injection BP, 250mg

OR

Cefuroxime Sodium injection USP, 250mg

Each vial to contain Cefuroxime Sodium BP/USP, equivalent to 250

mg of

Cefuroxime as sterile, dry, free flowing powder for reconstitution

with water

for injection BP/USP before use.

The reconstituted preparation should be suitable for slow

Intravenous injection,

Intravenous infusion and Intra-muscular injection.

Note:


WHO.

02. The product should be stable for a minimum of two years when

stored at a

temperature range of 25 C-30 C


Item Flupenthixol decanoate Inj.40mg/2ml 15,954 Amps

Specification Flupenthixol Injection BP 40mg/2ml.

Each 2ml ampoule to contain 40mg Flupenthixol decanoate in this

vegetable oil for intramuscular Injection.

Note:


stored with in the temperature range of 2'C - 8'C.


Item Donepezil Hydrochloridetablet 5mg 443,424 Tabs

Specification Donepezil tablets 5mg

Each tablet to contain 5mg of Donepezil Hydrochloride.

Note:


286 SR No 00304702

Item Flunarizine hydrochlorideTab. 5mg 3,639,801 Tabs

Page No 60 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Flunarizine hydrochloride Tablet 5mg

Each tablet to contain Flunarizine Hydrochloride equivalent to 5mg

of Flunarizine

Note:


287 SR No 00305201

Item Benztropine Inj. 2mg/2ml 3,798 Amps

Specification Benztropine Injection BP 2mg/2ml

OR

Benztropine Mesylate Injection USP 2mg/2ml

Each 2ml ampoule to contain 2mg of Benztropine Mesilate BP

OR

Benztropine Mesylate USP in water for Injection BP/USP for

intramuscular and


Note:



2.Each ampoules should be labelled accordingly.288 SR No 01402601

Item Colchicine tablet 500mcg 50,379 Tabs

Specification Colchicine tablets BP/USP 500mcg

Each tablet to contain 500mcg of Colchicine BP/USP

Note:



289 SR No 00301303

Item Amisulpride tablet 200mg 84,753 Tabs

Specification Amisulpride tablet 200mg

Each tablet to contain 200mg of Amisulpride BP/USP

Note:


290 SR No 01402201

Item Naproxen tablet 250mg 338,112 Tabs

Specification Naproxen tablet BP/USP 250mg

Each tablet to contain 250mg of Naproxen BP/USP

Note:

1. Shelf life of the product should be minimum of 24 months291 SR No 00502201

Item Desloratadine tablet 5mg 1,728,225 Tabs

Specification Desloratadine tablet 5mg

Each tablet to contain 5mg of Desloratadine BP.

Note:


292 SR No 00905101

Item Sodium Hyaluronate 1.8% 1ml ,Pre-filled syringe 6,525 PF.Syrs

Specification Sodium Hyaluronate 1.8% 1ml ,Pre-filled syringe

Sodium Hyaluronate Eye Drops, Each Pre-filled syringe to contain

1.8% Sterile Solution of Sodium Hyaluronate in a

physiological buffer.

Note:

1. The tamper evident Pre-filled syringe should assure the sterility of

the product.



3. Each Pre-filled syringe should be labelled accordingly.

Page No 61 of 89




NO OF ITEMS 418


ITEM QUANTITY

293 SR No 00102903

Item Erythromycin Syr. 125 mg/5ml,100ml 55,266 Bots

Specification Erythromycin Ethylsuccinate oral suspension BP/USP 125mg/5ml.

Each bottle to contain dry, free flowing powder/granules of

Erythromycin

Ethylsuccinate BP/USP with one or more suitable buffers, colours,

diluents,

dispersants in a flavoured vehicle suitable for reconstitution with

water before

use. The final volume of the reconstituted preparation should be

100ml. The

reconstituted preparation should contain Erythromycin

Ethylsuccinate BP/USP in a

concentration equivalent to 125mg of Erythromycin in 5ml.

Note:


WHO

2.A slightly oversize bottle should be provided to

facilitate reconstitution.

3.The bottle should be embossed at the 100ml level

or the label to indicate 100ml level.



294 SR No 00501402

Item Promethazine HCl Tab.25mg 1,232,886 Tabs

Specification Promethazine Hydrochloride BP, 25mg

Each coated tablet to contain 25mg of Promethazine Hydrochloride

BP

Tablet should also conform to dissolution test for Promethazine

Hydrochloride

Tablet as per USP

OR

Promethazine Hydrochloride Tablet USP, 25mg

Each coated tablet to contain 25mg of Promethazine Hydrochloride

USP.

Note:


295 SR No 01400303

Item Diclofenac sodium Supp. 12.5mg 18,171 Supps

Specification Diclofenac Sodium suppository 12.5mg

Each suppository to contain 12.5mg of Diclofenac Sodium in a

suitable

suppository base.

Note:


when stored

under tropical climatic condit.


Item Vinorelbine injection 50mgvial 807 Vials

Specification Vinorelbine Injection 50mg Vial

Each vial to contain 50 mg of Vinerolbine tartrate for intravenous

use.

Note:


2 years when stored under storage condition indicated by the

manufacturer


Page No 62 of 89




NO OF ITEMS 418


ITEM QUANTITY

297 SR No 00300502

Item Chloral hydrate Oral Solution500mg / 5ml in 200ml Bottle 921 Bots

Specification Chloral hydrate Oral Solution BP/USP, 500mg / 5ml in 200ml Bottle

Each 200ml bottle to contain 500mg / 5ml of solution of Chloral

hydrate BP/USP in a

suitable flavoured vehicle.

Note:

1. Shelf life of the product should be minimum of 24 months

2. The bottle should be labeled accordingly.

298 SR No 01402401

Item Meloxicam tablet 7.5mg 515,451 Tabs

Specification Meloxicam tablets BP 7.5mg

Each tablet to contains 7.5mg of Meloxicam BP

Note:


299 SR No 00800701

Item Ranitidine HCl Inj. 50mg/2mlamp 520,161 Amps

Specification Ranitidine Injection BP/USP, 50mg/2ml

Each 2ml ampoule to contain Ranitidine Hydrochloride BP/USP

equivalent to 50mg

of Ranitidine in Water for Injection BP/USP

Note:

01.Each ampoule should be labelled accordingly.


300 SR No 01103101

Item Selenium sulphide lotion2.5%,60ml bot 12,951 Bots

Specification Selenium Sulfite Lotion USP,2.5%w/v

Each 60ml bottle to contain 2.5% w/v of Selenium Sulfite USP in a

suitable base

for tropical use

Note;

01Each bottle should be labelled accordingly.


301 SR No 00203801

Item Nicorandil Tab. 10mg 12,786,024 Tabs

Specification Nicorandil tablet 10mg

Each tablet to contain 10mg of Nicorandil

Note:


302 SR No 01401201

Item Pyridostigmine Bromide Tab.60mg 301,191 Tabs

Specification Pyridostigmine Tablet BP. 60mg

Each tablets to contain 60mg of Pyridostigmine Bromide BP.

Tablets should also confirm to dissolution test for Pyridostigmine

Bromide

tablets as for USP

OR

Pyridostigmine Bromide Tablets USP 60mg

Each tablets to contain 60mg of Pyridostigmine Bromide USP

Note:


303 SR No 01000901

Item Oxytetracyclin3%+Hydrocortisone 1%, 15g 3,789 Tubes

Page No 63 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Oxytetracycline 3% with Hydrocortisone acetate 1% Ear ointment 15g

tube

Each 15g collapsible tube to contain Oxytetracycline 3% and

Hydrocortisone acetate 1% in a suitable ointment base for

ear use.

Note:






Item Calcipot 50mcg+Betameth oint.15g tube 17,160 Tubes

Specification Calcipotriol with Betamethasone ointment 15g tubes.

Each 15g collapsible tube to contain 50mcg/g of Calcipotriol and

Betamethasone

Dipropionate 0.5mg/g in a suitable ointment base.

Note:






Item Atomoxetine HCl capsule 10mg 61,350 Caps

Specification Atomoxetine hydrochloride capsule 10mg

Each capsule to contain Atomoxetine hydrochloride equivalent to

10mg of

Atomoxetine

Note:


306 SR No 00301201

Item Zuclopenthixol acetate Inj.50mg/1ml 528 Amps

Specification Zuclopenthixol Acetate BP, 50mg/1ml

Each 1ml ampoule to contain 50mg of Zuclopenthixol Acetate BP in

suitable

vegetable oil for intramuscular injection.

Note:

1. The Injection should be stable for minimum of 24 months when



Item Dydrogesterone tablet. 10mg 28,251 Tabs

Specification Dydrogesterone tablet 10mg BP

Each tablet to contain 10mg of Dydrogesterone BP

Note:

1.Tablets should be protected from light.


308 SR No 00501001

Item Montelukast Sodium chewableTab. 5mg 434,607 Tabs

Page No 64 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Montelukast Sodium chewable tablets BP 5mg

Each coated tablets to contains 5mg of Montelukast sodium BP

Note:


309 SR No 00306801

Item Alprazolam tablet 0.25mg 214,692 Tabs

Specification Alprazolam tablets USP 0.25 mg

Each tablet to contain 0.25mg of Alprazolam USP

Note:


when stored


02.The Product should be protected from light and dispensed in

tight,

light-resistant container.

03.Each pack should be labeled accordingly.310 SR No 00701501

Item Hydrocortisone tablet 5mg 106,254 Tabs

Specification Hydrocortisone Tablets USP 5mg

Each tablet to contain 5mg of Hydrocortisone USP.

Note:


311 SR No 01300302

Item Dinoprostone vaginal gel1mg/2.5ml tube 4,446 Tubes

Specification Dinoprostone vaginal gel 400mcg/ml ,2.5ml Tube

Each tube to contain 400mcg/ml of Dinoprostone BP/USP.

Note:


312 SR No 01107301

Item Fusidic acid 2%+Betamethasone0.1% cream 15g tube 21,822 Tubes

Specification Fusidic acid 2%+Betamethasone 0.1% cream 15g tube

Each 15g tube to contain Fusidic acid Ph.Eur. 2% and Betamethasone

0.1% (as the valerate ester).

Note:


stored at a temperature range of 28'C - 32'C.



cartons.313 SR No 00901201

Item Atropine sulphate Eye Drops1% 5ml 4,344 Vials

Page No 65 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Atropine sulphate Eye Drops BP, 1%w/v

Each 5ml dropper bottle to contain 1%w/v sterile solution of

Atropine sulphate

BP in purified water

OR

Atropine sulfate Ophthalmic Solution USP 1%w/v

Each 5ml dropper bottle to contain 1%w/v sterile solution of

Atropine Sulfate

USP in purified water

Note;

1.The sealed tamper evident dropper bottle should assure the

sterility of the

product.

2.Product should be packed in light resistant containers/boxes.

3.Product should be stable for a minimum of 24 months when stored

within a


4.Each botle should be labelled accordingly.314 SR No 01302001

Item Oxybutynine Hydrocloride tablet 2.5mg 63,294 Tabs

Specification Oxybutynine tablet BP 2.5mg

Each tablet to contain Oxybutynine Hydrocloride BP 2.5mg

OR

Oxybutynine Chloride tablets USP 2.5mg

Each tablet to contain Oxybutynine Chloride USP 2.5mg

Note:


315 SR No 00206301

Item Activated Prothrombin ComplexConcentrate Injection 500IU 789 Vials

Specification Activated Prothrombine Complex Concentrate Injection 500IU vial

(Activated concentrates: By passing agents)

Each vial to contain Human plasma fraction with a factor Eight

inhibitor by passing activity and it

should contain Factors II,IX,X ,mainly in inactive form as factor VII

mainly in the activated form.

The product should contain approximately equal units of factor eight

by passing activity and prothrombin complex

factors.

Note:

1. The item should be stable at temperature 2'C - 8'C.

2. The product should have minimum 24 months shelf life at the time

of delivery to MSD.

3. Tender should submit detail specifications of the product offered

including a product leaflet.

4. The product should ensure, at least two steps on virus inactivation

as recommended by WHO/US.FDA

5. The donor selection process should be specified by the

manufacturer.

6. Each batch should be certified as free from HIV and hepatitis

viruses.

7. Anti viral test methods used for screening for HIV and Hepatitis

viruses should be declared by the manufacturer. This

test methods used should be approved by WHO/US.FDA.

8. Each vial to be submitted with suitable diluent.

9. The product should be protected from light.316 SR No 00208601

Item Metolazone tablet 5mg 106,149 Tabs

Page No 66 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Metolazone tablets USP 5mg

Each tablet to contain 5mg of Metolazone USP

Note:


02.The product should be kept in tight, light resistant containers,and

store below 30'C.

317 SR No 01202602

Item Vinorelbine Injection10mg Vial 660 Vials

Specification Vinorelbine Injection 10mg Vial

Each vial to contain 10 mg of Vinerolbine tartrate for intravenous

use.

Note:


2 years when stored under storage condition indicated by the

manufacturer


Item Cytarabine inj. 100mg vial 3,615 Vials

Specification Cytarabine Injection BP 100mg/5ml

Each 5ml vial to contain 100mg of Cytarabine BP in water for

injection BP/USP

for intravenous and subcutaneous injection

OR

Cytarabine for Injection BP/USP 100mg.

Each vial to contain 100mg of Cytarabine BP/USP as sterile dry

powder for


intravenous and

subcutaneous injection

Note:

1.This injection should be stable for 24 months when

stored at a temperature range of 28'C - 32'C


Item pizotifen tablet 0.5mg 114,363 Tabs

Specification Pizotifen Tablet BP 0.5mg

Each tablet to contain 0.725mg pizotifen malate BP, equivalent to

0.5mg of pizotifen base

Note:


02. The product should be protected from light.

320 SR No 01206502

Item Megestrol acetate tablet 160mg 2,319 Tabs

Specification Megestrol Tablets BP

OR

Megestrol Acetate Tablets USP

Each tablet to contain 160mg of Megestrol Acetate BP/USP

Note:


321 SR No 00300501

Item Chloral hydrate Cry. 35,214 gs

Page No 67 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Chloral Hydrate BP (Crystals)

OR

Chloral Hydrate USP (Crystals)

Note:


322 SR No 00105601

Item Norfloxacin Tab. 400 mg 288,489 Tabs

Specification Norfloxacin tablets BP/USP 400 mg

Each tablet to contain 400 mg of Norfloxacin BP/USP.

Note:


323 SR No 00107201

Item Itraconazole Cap. 100mg 489,909 Caps

Specification Itraconazole capsule 100mg

Each capsule to contain 100mg of Itraconazole.The Capsule should

conforms to bio equivalence criterion Of the WHO

Note:


324 SR No 00304402

Item Lamotrigine tablet 50mg 498,051 Tabs

Specification Lamotrigine tablets BP 50mg

Each tablet to contain 50mg of Lamotrigine BP

Note:


325 SR No 00305701

Item Paracetamol 500mg +Codein 8mg(Co-codamol 8mg/500mg) tablet 2,721,987 Tabs

Specification Paracetamol 500mg + Codein phosphate 8mg tablet (Co-codamol

tablet 8mg/500mg)

Each tablet to contain 500mg of Paracetamol and 8mg of Codein

phosphate

Note:


02.Product should be protected from light

326 SR No 01402301

Item Celecoxib capsule 100mg 1,852,305 Caps

Specification Celecoxib capsule 100mg

Each capsule to contains 100 mg celecoxib.

Note :


327 SR No 00306601

Item Pregabalin capsule 75 mg 710,001 Caps

Specification Pregabalin capsule 75 mg

Each capsule to contain 75 mg of pregabalin.

Note:


328 SR No 00200303

Item Furosemide(Frusemide) Inj.100mg/10ml 32,133 Amps

Page No 68 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Furosemide Injection BP/USP, 100mg/10ml

OR

Frusemide Injection BP, 100mg/10ml

Each 10ml amber coloured ampoule to contain Furosemide Sodium

equivalent to 100mg of Furosemide BP/USP or Frusemide BP

for, slow intravenous and intravenous infusion.

Note:


2 years when stored at at a temperature range of 28'C-32'C


329 SR No 00304302

Item Gabapentin Capsule 100mg 2,048,700 Caps

Specification Gabapentin Capsule 100mg

Each capsule to contain 100mg of Gabapentin USP

Note:


330 SR No 00205701

Item Alteplase 20mg vial 330 Vials

Specification Alteplase (Recombinent Tissue type plasminogen activator) 20mg vial

Each vial to contain 20mg of Alteplase for intravenous injection

Note;

1.The product should be from freshly manufactured stock

and should have a minimum shelf life of 24 months.


331 SR No 00102603

Item Amikacin inj. 500mg in 2ml 54,615 Vials

Specification Amikacin Sulphate Injection USP 500mg in 2ml vial

Each vial to contain 500mg of Amikacin Sulphate USP in water for

injection

BP/USP for Intravenous or Intramuscular Injection.

Note:


WHO.




Item Urea Crystals 375,999 gs

Specification Urea crystals BP/USP

Packing: 100g in an air tight cotainer

Note:


333 SR No 00103801

Item Sulphadiazine Tab. 500mg 3,153 Tabs

Specification Sulfadiazine Tablets USP 500mg

Each tablet to contain 500mg of Sulfadiazine USP.

Note:


334 SR No 01103401

Item Permethrin cream 5%, 15g tube 61,110 Tubes

Page No 69 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Permethrin Cream 5%w/w

Each 15g tube to contain 5%w/w of Permethrin in suitable cream

base for topical

use.

Note:






Item Carbamazepine syrup 100mg/5ml,100 ml bottle 2,232 Bots

Specification Carbamazepine oral suspension USP 100mg/5ml, 100ml bottle

Each 100ml bottle to contain 100mg/5ml of Carbamazepine in a

suitable flavoured

and sweetened syrup/suspension base

Note:

01. The Product should be free from alcohol


336 SR No 01107002

Item Benzoyl peroxide gel 2.5%,20gtube 12,546 Tubes

Specification Benzoyl peroxide gel BP 2.5%,20g tube

Each 20g collapsible tube to contain Hydrous Benzoyl peroxide

equivalent to 2.5%(w/w)of benzoyl peroxide BP in suitable water-

soluble basis.

OR

Benzoyl peroxide gel USP 2.5%,20g tubes

Each 20g collapsible tube to contain 2.5%(w/w) of Benzoyl peroxide

USP in

suitable gel base.

Note:


stored at a temperature range of 28'C - 32'C.

2.Each tube should be labeled accordingly.

3.Each collapsible tubes should be printed, air tight in printed

cartoons.337 SR No 00402701

Item Vitamin B1 Tab. 10mg 3,161,250 Tabs

Specification Thiamine Tablets BP 10mg. (Vitamin B1 Tablets)

Each tablet to contain 10mg of Thiamine Hydrochloride BP. Tablet

should also conform to dissolution test for Thiamine

Hydrochloride as per USP.

OR

Thiamine Hydrochloride tablets USP, 10mg.

Each tablet to contain 10mg of Thiamine Hydrochloride USP

Note:

01.Tablet should be kept free from contact with metal and protected

from light.


338 SR No 01104901

Item Sulphur precipitated powder 82,314 gs

Page No 70 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Precipitated Sulphur BP

or

Precipitated Sulphur USP (As very fine, amorphours powder)

Packing: 500g should be packed in well closed container

Note:


339 SR No 00103101

Item Azithromycin Tab.250mg 1,267,527 Tabs

Specification Azithromycin tablets BP/USP 250mg

Each tablet to contain 250mg of Azithromycin BP/USP.

Note:



340 SR No 01203701

Item Cisplatin injection 10mg vial 1,371 Vials

Specification Cisplatin injection BP, 10mg/10ml

Each 10ml vial to contain 10mg of Cisplatin BP in water for injection

BP/USP

for intravenous injection.

OR

Cisplatin for injection BP/USP, 10mg

Each vial to contain 10mg Cisplatin BP/USP as sterile dry powder for

reconstitution with water for injection BP/USP, before use for

intravenous

injection

Note:


months when stored under temperature range of

15 C - 30 C. Protect from light.


341 SR No 00901901

Item Pilocarpin nitrate Eye Drop1%,10ml vial 1,383 Vials

Specification Pilocarpine Nitrate Eye Drops BP, 1% 10ml,

Each 10ml dropper bottle to contain 1% w/v of Pilocarpine Nitrate BP

in purified

water

OR

Pilocarpine Nitrate Ophthalmic solution USP 1% w/v, 10ml

Each 10ml dropper bottle to contain 1% w/v of Pilocarpine Nitrate

USP in

purified water

Note:




3.The Product should be stable for a minimum of 24 months

when stored at a temperature range of 28'C-32'C

4.Each bottle should be labelled accordingly342 SR No 00301301

Item Zuclopenthixol Deco. inj.200mg/ml 1,842 Amps

Page No 71 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Zuclopenthixol Deconate injection BP,200mg/ml

Each 1ml ampoule to contain 200mg of Zuclopenthixol Deconate BP

in suitable

vegitable oil for deep intramuscular inlection

Note;

1.The product should be protected from light and stored

at a temperature not exeeding 25'C'

2.The Injection should be stable for a minimum of 24

months when stored under stipulaled conditions

2.Each ampoule to be labelled accordingly.343 SR No 00305004

Item Co-careldopa Modified Releasetablet 50mg/200mg 150,501 Tabs

Specification Co-careldopa Modified Release tablet 50mg/200mg

Each modified release tablet to contain 200 mg of Levodopa BP/USP

and

Carbidopa BP/USP(equivalent to 50 mg of anhydrous Carbidopa)

Note:


344 SR No 00404501

Item Disodium hydrogenorthophosphate Pow. 69 kgs

Specification Disodium hydrogen orthophosphate powder for medical use

(Ingredient for buffer solution to be administered orally)

Note:

01.The maximum limit of Arsenic content of the product should

accordance with BP 2007


345 SR No 00900301

Item Tetracycline Eye Oint. 1%,3.5g 12,783 Tubes

Specification Tetracycline Hydrochloride Ophthalmic Ointment USP 1% w/w, 3.5g

Tube

Each 3.5g collapsible tube to contain 1% w/w of Tetracycline

Hydrochloride USP

in suitable eye ointment base.

Note:



2. Each tube should be labelled accordingly.



Item Levetiracetam Tablets 250mg 724,563 Tabs

Specification Levetiracetam tablets 250mg

Each coated tablet to contain 250mg of Levetiracetam

Note:


347 SR No 00401103

Item Dextrose for IV use 25% , 25ml 229,944 Vials

Page No 72 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Glucose intravenous infusion BP, 25% w/v or Dextrose Injection USP

25% w/v.

Each 25ml vial to contain 25% w/v of anhydrous Glucose

BP/anhydrous Dextrose USP

in water for injection BP/USP for intravenous infusion.

Note:

1.Product should be stable for a minimum of 24

months when stored under at a temperature range of 28'C-32'C


348 SR No 00108302

Item Linezolid tablet 600mg 17,835 Tabs

Specification Linezolid tablet 600mg

Each tablet to contain 600 mg of linezolid

Note:


349 SR No 00305301

Item Botulinum Toxin 100U Vial 1,497 Vials

Specification Botulinum A Toxin

Each vial to contain 100 IU of Botulinum A toxin haemaglutinin

complex as

sterile powder for reconstitution.

Note:


stored at a temperature of 2'C-8'C


Item Thymol crystals 46,587 gs

Specification Thymol BP/USP, (Crystals)

Pack; 50g in an airtight container

Note:


351 SR No 01204201

Item Everolimus tablet 0.25mg 84,159 Tabs

Specification Everolimus tablet 0.25mg

Each tablet to contain 0.25mg of Everolimus.

Note:


352 SR No 00307301

Item Ropinirole tablet 0.5mg 221,199 Tabs

Specification Ropinirole tablets 0.5mg

Each coated tablet to contain Ropinirole hydrochloride

equivalent to 0.5mg of Ropinirole base.

Note:


353 SR No 00901101

Item Fluorometholone Eye drops0.1,5ml 36,135 Vials

Page No 73 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Fluorometholone Eye drops BP, 0.1%w/v, 5ml dropper bottle

Each 5ml dropper bottle to contain 0.1%w/v of sterile suspension of

Fluorometholone in purified water.

OR

Fluorometholone ophthalmic suspension USP, 0.1%w/v, 5ml dropper

bottle

Each 5ml dropper bottle to contain 0.1%w/v of sterile suspension of

Fluorometholone in suitable aqueous medium.

Note:






Item Glycerin 995,781 mls

Specification Glycerol BP OR Glycerin USP 99.7%

Note:


2.Should have a valid registration from NMRA.

3.The supplier should provide a certificate endorsing good


certification). 4. should be supplied in air tight sealed containers with

a screw cap.

5.Should have a valid registration from NMRA.

6.The supplier should provide a certificate endorsing good


certification). 7. Each bottle should be clearly labeled accordingly

with the indications for use, strength of the

solution. Label should have letters of readable size.

8.There should be a leaflet with each container giving relevant

information such as chemical composition and strength.

9.Should have a minimum of 12 months shelf life when stored at

28¿C- 32¿C.

355 SR No 01201201

Item Epirubicin hydrochloride Inj.10mg vial 2,673 Vials

Specification Epirubicin Hydrochloride for injection 10mg vials.

Each vial to contain 10mg of Epirubicin Hydrochloride (CAS-56390-09-

01) as

sterile dry powder for reconstitution with water for injection BP/USP

before use

for intravenous infusion

OR

Epirubicin Hydrochloride injection 10mg/5ml

Each 5ml vial to contain 10mg of Epirubicin Hydrochloride (CAS-

56390-09-1) in a

suitable vehicle for intravenous infusion.

Note:


months when stored within a temperature range of

2'C - 8'C

2. Each vial should be packed in light resistant box.

3. Each vial should be labelled accordingly356 SR No 00101801

Item Cefixime dispersible tablet100mg 58,674 Tabs

Page No 74 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Cefixime dispersible tablet USP, 100mg

Each dispersible tablet to contain Cefixime USP, equivalent to 100mg

of

Cefixime.

Note:


WHO.


357 SR No 00101101

Item Sulbactam/Cefoperazone Inj.1g vial 28,281 Vials

Specification Sulbactam sodium and Cefoperazone sodium for injection 1g vial

Each vial to contain Sulbactam sodium equivalant to 0.5g of

Sulbactam BP/USP and

Cefoperazone sodium BP/USP equivalant to 0.5g of Cefoperazone as

a sterile dry powder

for reconstitution with suitable diluent for intramuscular or

intravenous use.

Note:


WHO.

02.The product should be stable for 02 years when



358 SR No 01400101

Item Methyl salicylate 6,466,662 mls

Specification Methyl Salicylate BP

OR

Methyl Salicylate USNF

Pack: 500ml in well-closed, light resistant glass bottle

Note:


359 SR No 00101704

Item Ceftriaxone Inj. 1g 478,008 Vials

Specification Ceftriaxone for injection USP 1g

Each vial to contain sterile Ceftriaxone sodium USP equivalent to 1g

of

Ceftriaxone as sterile dry powder for reconstitution with water for

injection

BP/USP for intravenous injection

Note:


WHO.


years when stored under temperature not exceeding 30'C


Item Dacarbazine injection 200mgvial 2,478 Vials

Specification Dacarbazine for injection BP/USP 200mg.

Each vial to contain 200mg of Dacarbazine BP/USP as sterile free

flowing powder

for reconstitution before use for intravenous infusion.

Note:


24 months when stored within temperature range of 2'C - 8'C

2.Product should be packed in light resistant boxes/containers.


Item Gemcitabine hydrochlorideinj.1g 7,035 Vials

Page No 75 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Gemcitabine Injection 1g vial

Each vial to contain Gemcitabine Hydrochloride as sterile dry powder

for

reconstitution with water for injection for intravenous injection or

intravenous

infusion.

1. The product should be stable for minimum of 24 months when

stored under


2. Each vial to be labelled accordingly.362 SR No 00405302

Item Albumin solution (human) 5%,250ml 4,890 Bots

Specification Albumin solution BP/Ph Eur(human), 5% in 250ml bottle

Each 250ml bottle to contain 5% of Albumin solution BP and at least

95% of the

Albumin Protein BP (Ph Eur) derived from human plasma serum.

OR

Albumin Human USP 5% in 250ml bottle

Each 250ml bottle to contain 5% of Albumin Human USP 5% and at

least 95% of the

Albumin Protein USP derived from human plasma serum.

Note:


as

recommended by WHO.

2.The product should be stable for minimum of 02 years

when stored under 2'C - 8'C.

3.Each bottle should be labeled accordingly

363 SR No 00103602

Item Teicoplanin Inj. 400mg Vial 25,194 Vials

Specification Teicoplanin Injection 400mg vial

Each vial to contain 400mg of Teicoplanin as sterile dry powder for

reconstitution for intramuscular or intravenous use

Note:




364 SR No 00103401

Item Sodium Fusidate Tab. 250mg 28,296 Tabs

Specification Sodium Fusidate tablet 250 mg

Each tablet to contain 250mg of Sodium Fusidate BP.

Note:

01.Product should conform to bio equivalence criteria of the WHO


365 SR No 00300301

Item Lorazepam Tab. 1mg 283,449 Tabs

Specification Lorazepam Tablet USP, 1mg

Each tablet to contain Lorazepam USP

Note:


366 SR No 00203601

Item Nimodipine Tab. 30mg 54,099 Tabs

Page No 76 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Nimodipine Tablet BP 30mg.

Each coated tablet to contain 30mg of Nimodipine BP.

Note:


367 SR No 00402804

Item Pyridoxine Hydrochloridetablet 100mg 14,274 Tabs

Specification Pyridoxine Tablets BP 100mg

Each tablet to contain 100mg of Pyridoxine Hydrochloride BP.

Tablet should also conform to dissolution test for Pyridoxine

Hydrochloride tablet as per USP.

OR



Note:

01.Sufficient overage to be added to ensure the adequate shelf life


03.Tablets should be protected from light

368 SR No 00101303

Item Cefalexin dispersible tablet125mg 1,409,364 Tabs

Specification Cefalexin dispersible tablet 125mg

Each dispersible tablet to contain Cefalexin Monohydrate BP,

equivalent to 125mg

of Cefalexin.

Note:

01.Tablet should conform to bio equivalence criteria Of the WHO.



369 SR No 00703301

Item Desmopresin tablet 100mcg 16,434 Tabs

Specification Desmopressin tablet 100mcg BP

Each tablet to contain 100mcg of Desmopressin acetate BP.

Note:

01.Tablets should be protected from light.


370 SR No 01401302

Item Baclofen tablet 10mg 859,599 Tabs

Specification Baclofen tablets BP/USP 10mg.

Each tablet to contain 10mg of Baclofen BP/USP.

Note:

01.The tablets should be preserved in well closed containers.


371 SR No 00706501

Item Sitagliptin tablet 100mg 12,781,101 Tabs

Specification Sitagliptin tablet BP 100mg

Each tablet to contain 100mg of Sitagliptin BP

Note:


372 SR No 00703101

Item Human Chorionic Gonadortophin5000 IU 6,147 Vials

Page No 77 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Human Chorionic Gonadortophin 5000 IU

Each vial to contain 5000 IU of human Chorionic Gonadotrophin

(hCG) freeze-dried powder for injection

Note:


stored within temperature range of 2'C - 8'C.


Item Balanced salt, Solu. 500mlglass bottle 3,525 Bots

Specification Balanced salt solution for ophthalmic use

Each 500ml glass bottle to contain sterile solution of 0.64% of Sodium

Chloride 0.39% of Sodium Acetate 0.17% of Sodium

Citrate, 0.048% of Calcium Chloride 0.03% of Magnesium Chloride

and 0.075% of Potassium Chloride in a suitable base to

use with "Constellation" vitrectomy machine.

Note :

01. Each bottle to be labelled accordingly.


374 SR No 01205501

Item Basiliximab injection 20mg 231 Vials

Specification Basiliximab injection 20mg for IV use with solvent 5ml

Each 5ml vial to contain 20 mg of Basiliximab with a suitable solvent

for

intravenous use.

Note :

1.The product should be stable for a minimum of 24 months when

stored within a



Item Methylprednisolone IA Inj.40mg/1ml 29,508 Vials

Specification Methyl Prednisolone Acetate injection BP 40mg/ml

Each 1ml vial to contain 40mg of Methyl Prednisolone Acetate BP in

water for

injection BP/USP,for intramuscular, Intra-articular Injection

OR

Methyl Prednisolone Acetate injectable suspension USP 40mg/ml

Each 1ml vial to contain 40mg of sterile Methyl Prednisolone Acetate

USP in

water for injection USP for Intramuscular,1ntra-articular injection

Note:

1. The product Should be stable for minimum of 24 months when


2. Each vial should be labelled accordingly.

376 SR No 01302201

Item Sevelamer hydrochloride tablet 800mg 51,708 Tabs

Specification Sevelamer hydrochloride tablet 800mg

Each coated tablet to contain 800 mg of sevelamer hydrochloride

Note:


377 SR No 01402501

Item Febuxostat tablet 40mg 22,026 Tabs

Page No 78 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Febuxostat tablets 40mg

Each tablet to contains 40mg of Febuxostat.

Note:


378 SR No 00201601

Item Metoprolol Tab. 50mg 6,076,500 Tabs

Specification Metoprolol tartrate tablets BP/USP 50mg

Each tablet to contain Metoprolol tartrate BP/USP 50mg

Note :



379 SR No 00302201

Item Amitriptyline Tab. 10mg 1,187,175 Tabs

Specification Amitriptyline Tablets BP 10mg

Each coated tablet to contain 10mg of Amitriptyline Hydrochloride

BP

Tablet should also conform to dissolution test for Amitriptyline

Hydrochloride

Tablets as per USP

OR

Amitriptyline Hydrochloride Tablets USP, 10mg

Each coated tablet to contain 10mg of Amitriptyline Hydrochloride

USP

Note:


380 SR No 00801203

Item Bisacodyl suppository 10mg 68,382 Supps

Specification Bisacodyl Suppository BP/USP 10mg (Adult).

Each suppositiry to contain 10mg Bisacodyl BP/USP in a suitable

suppositiry base to be used in a temperature range of

28'C-32'C

Note:

1. This suppositiry should be stable for a minimum of 24 months


2. Each suppositiry should be labelled accordingly.381 SR No 00703901

Item Cabergoline tablet 500mcg 24,795 Tabs

Specification Cabergoline tablet 500mcg

Each tablet to contain 500mcg of Cabergoline BP.

Note:


382 SR No 01210101

Item Mesna injection 200mgin 2ml 7,848 Vials

Specification Mesna injection 200mg in 2ml

Each vial to contain aqueous solution of mesna (sodium 2-mercapto-

ethanesulphonate) 200 mg in 2 ml intravenous

injection

Note:


stored below 30'C

2.This injection should be protected from light.


Item Temozolomide capsule 100mg 8,487 Caps

Page No 79 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Temozolomide capsule 100mg

Each capsule to contain Temozolomide 100mg

Note:


384 SR No 00304601

Item Ethosuximide Cap 250mg 69,903 Caps

Specification Ethosuximide Capsule BP/USP 250mg.

Each capsule to contain 250mg of Ethosuximide BP/USP

Note:


385 SR No 00103201

Item Clindamycin Cap. 150mg 271,212 Caps

Specification Clindamycin Capsules BP,150mg

OR

Clindamycin Hydrochloride Capsules USP,150mg

Each capsule to contain Clindamycin Hydrochloride BP/USP


Clindamycin.

Note:

01.Product should conform to bio equivalence criteria Of the WHO


386 SR No 00102001

Item Imipenem Inj. 500mg 79,878 Vials

Specification Imipenem and Cilastatin for injection USP, 500mg.

Each vial to contain mixture of Imipenam Monohydrate USP


Imipenam and Cilastatin Sodium equivalent to 500mg of Cilastatin as

sterile dry

powder for reconstitution for intramuscular and intravenous

injection or


Note:


WHO.

2.The product should be stable for 02 years when stored under

controlled room temperature.


Item Betahistine tablet 8mg 1,497,000 Tabs

Specification Betahistine tablet BP 8mg

Each tablet to contain Betahistine Dihydrochloride equivalent to 8mg

of

Betahistine

Note:


388 SR No 00404401

Item Sodium dihydrogenorthophosphate Pow. 69 kgs

Specification Sodium dihydrogen orthophosphate powder for medical use

(Ingredient for buffer solution to be administered orally)

Note:

01.The maximum limit of Arsenic content of the product should

accordance with BP 2007


389 SR No 00905001

Page No 80 of 89




NO OF ITEMS 418


ITEM QUANTITY

Item Sodium Hyaluronate 3% + SodiumChondrotin Sulfate4%,0.5ml PFS 6,255 PF.Syrs

Specification Sodium Hyaluronate 3% + Sodium Chondrotin Sulfate 4%,0.5ml PFS

Sodium Chondroitin sulfate with Sodium Chondroitin sulfate

Solution ,Each 0.5ml Pre-filled to contain sterile

solution of Sodium Chondroitin sulfate 4%, Sodium Hyaluronate 3%

in a physiological buffer solution.

Note: 1. The tamper evident Pre-filled syringe should assure the



stored at temperature 32'C

3. Each Pre-filled syringe should be labelled accordingly.

390 SR No 00403501

Item Hydroxocobalamine Inj. 1mg/1ml 58,455 Amps

Specification Hydroxocobalamine injection BP.

Each 1ml amber coloured ampoule to contain 1mg of anhydrous

Hydroxocobalamine BP

for intramuscular injection.

OR

Hydroxocobalamine injection USP.

Each 1ml amber coloured ampoule to contain 1mg of anhydrous

Hydroxocobalamine

USP for intramuscular injection.

Note:

1. The injection should be stable for a minimum of 24 months when

stored

at a temperature range of 28'C-32'C.

2. Each ampoule should be labeled accordingly.391 SR No 00304403

Item Lamotrigine tablet 100mg 175,674 Tabs

Specification Lamotrigine tablets BP 100mg

Each tablet to contain 100mg of Lamotrigine BP

Note:


392 SR No 01107101

Item Clindamycin gel 1% w/w ,30gtube 11,352 Tubes

Specification Clindamycin phosphate gel BP/ USP 1% w/w ,30g tube

Each 30g tube to contain 1% w/w of Clindamycin as Clindamycin

phosphate

Note:


02. Each tube should be labelled accordingly

393 SR No 00103202

Item Clindamycin Cap. 300mg 603,834 Caps

Specification Clindamycin Capsules BP 300mg

OR

Clindamycin Hydrochloride Capsules USP 300mg.

Each capsule to contain Clindamycin hydrochloride BP/USP,

equivalent to 300mg

of Clindamycin.

Note:

01. Product should conform to bio equivalence criteria Of the WHO


394 SR No 01102001

Page No 81 of 89




NO OF ITEMS 418


ITEM QUANTITY

Item Clobetasol ointment 0.05%,15gtube 155,550 Tubes

Specification Clobetasol Ointment BP,0.05%w/w,

OR

Clobetasol Propionate ointment USP 0.05%w/w

Each 15g tube to contain 0.05%w/w of Clobetasol Propionate BP/USP

in a suitable

ointment base

Pack; 15g in air tight, sealed, printed collapsible tubes in printed

cartons.

Note;

1.The ointment should be stable for a minimum of 24


2.Each tube should be labelled accordingly.395 SR No 00904401

Item Trypan Blue ophthalmicsolution 0.06% ,1ml vial /PFS 7,029 Vials

Specification Trypan Blue ophthalmic solution 0.06%, 1ml vial /PFS

Each 1 ml vial / Pre-filled syringe to contain 0.06 % w/v sterile

solution of Trypan Blue

Note:

1. The tamper evident dropper bottle / Pre-filled syringe should





396 SR No 00300105

Item Diazepam rectal solution10mg in 2.5ml Tube 1,170 Tubes

Specification Diazepam rectal solution 10mg in 2.5ml Tube

Each 2.5ml tube to contain 10mg of Diazepam BP/USP as solution for

rectal use.

Note:

01.The tube should be suitably formulated for rectal use.


397 SR No 00905301

Item Brinzolamide10 mg/1ml+timolol malete 5mg /1ml,5ml 11,265 Bots

Specification Brinzolamide 10 mg/1ml with Timolol maleate 5 mg /1 ml eye drop in

5ml dropper bottle,

Each 5ml dropper bottle to contain 10mg /1 ml of Brinzolamide USP

and 5mg/ml of Timolol USP (as Timolol maleate)

suspension for opthalmic use.

Note:


398 SR No 00306401

Item Oxcarbazepine tablet 150mg 561,912 Tabs

Specification Ox-carbazepine tablet 150mg

Each coated tablet to contains 150mg of oxcarbazepine

Note:


399 SR No 00400401

Item Iron sucrose Inj. 100mg in 5ml 44,298 Amps

Page No 82 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Iron Sucrose solution for injection / Infusion

Each 5ml ampoule to contain 20mg/ml of Iron as Iron Sucrose

solution for

intravenous injection or intravenous infusion.

Note:




Item Docusate sodium Ear Drop.0.5%,10ml vial 2,841 Vials

Specification Docusate Sodium BP/USP 0.5% w/v Ear Drops

Each 10 ml dropper bottle to contain sterile solution of Docusate

Sodium BP/USP

Note:




boxes.




Item Methoxsalen tablet 10mg 18,138 Tabs

Specification Methoxsalen Tablet 10mg

Each tablet to contain 10mg of Methoxsalen USP

Note:

01. Analytical method could be apply as per Methoxsalen capsules

USP


402 SR No 00101703

Item Ceftriaxone Inj. 500mg 78,060 Vials

Specification Ceftriaxone Injection USP/BP, 500mg Vial

Each vial to contain sterile Ceftriaxone sodium USP/BP equivalent to

500mg of

Ceftriaxone as sterile dry powder for reconstitution with water for

injection

BP/USP for intravenous injection

Note:


WHO.


stored under

temperature not exceeding 30'C


Item Conjugated Estrogens tablet0.625mg 39,729 Tabs

Specification Conjugated Oestrogens Tablets USP 625mcg

Each tablet to contain 625mcg of Conjugated Oestrogens USP.

Note:


404 SR No 00704501

Item Triamcinolone acetonide Inj40mg/ml 2,154 Vials

Page No 83 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Triamcinolone acetonide injection BP 40mg in 1ml vial.

Each vial to contain 40mg of Triamcinolone acetonide BP as sterile

suspension in very fine particles, in water for

injections containing suitable dispersing agents for intra- articular or

intramuscular use.

OR

Triamcinolone acetonide injection USP 40mg in 1ml Vial.

Each vial to contain 40mg of Triamcinolone acetonide USP,as sterile

suspension in a suitable aqueous medium for

intra-articular or intramuscular use.

Note:

1. Injections should be protected from light.


Item Pamidronate disodium Inj. 30mg 1,740 Vials

Specification Disodium Pamidronate for Intravenous Infusion BP 30mg vial

Each vial to contain 30mg of Disodium Pamidronate as sterile dry

powder for


intravenous

infusion

Note:


years when stored between 30'C - 35'C


Item Phenylephrine inj. 10mg/1mlvial 1,941 Vials

Specification Phenylephrine injection BP 10mg/1ml

OR

Phenylephrine Hydrochloride Injection USP 10mg/1ml

Each 1ml vial to contain 10mg of Phenylephrine Hydrochloride

BP/USP 10mg for

subcutaeneous injection, intramuscular injection slow intravenous

injection or


Note:


407 SR No 01207302

Item Goserelin acetate implant10.8mg (in syringe applicator) 246 PF.Syrs

Specification Goserelin Acetate 10.8mg implant in syringe applicator.

Each implant to contain Goseraline Acetate Ph Eur 10.8mg for

subcutaneous use.

Note;

1.The product should be stable for a minimum of 02 years

when stored below 25' C and Protected from light

2.Each implant should be labelled accordingly.408 SR No 01202401

Item Vincristine sulphateinjection 1mg vial 8,094 Vials

Page No 84 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Vincristine Sulphate for Injection BP/Vincristine Sulfate USP 1mg

Each vial to contain Vincristine Sulphate BP/Vincristine Sulfate USP

equivalent

to 1mg of Vincristine and 10 parts by weight of Lactose BP/USP as

sterile dry

powderfor reconstitution for intravenous use

OR

Vincristine injection BP 1mg/ml

Each vial to contain Vincristine Sulphate BP equivalent to 1mg/ml of

Vincristine

in 0.9% w/v of Sodium Chloride intravenous infusion BP as ready to

use injection

for intravenous use.

Note:


months when stored within a temperature range of

2'C - 8'C, do not freeze

2.Each dry powder form vial should be provided with a

suitable diluent.


409 SR No 00205601

Item Dipyridamole Tab.100mg 2,300,724 Tabs

Specification Dipyridamole Tablet BP/USP 100mg

Each coated tablet to contain 100mg of Dipyridamole BP/USP

Note:


410 SR No 00901903

Item Pilocarpin nitrate Eye Drop4%,10ml vial 846 Vials

Specification Pilocarpine Nitrate Eye Drops BP, 4% 10ml,

Each 10ml dropper bottle to contain 4% w/v of Pilocarpine Nitrate BP

in purified

water

OR

Pilocarpne Nitrate Ophthalmic solution USP 4% w/v, 10ml

Each 10ml dropper bottle to contain 4% w/v of Pilocarpine Nitrate

USP in

purified water

Note:




boxes.

3.Product should be stable for a minimum of 24 months



Item Levetiracetam Tablets, 500 mg 1,040,934 Tabs

Specification Levetiracetam tablets 500mg

Each coated tablet to contain 500mg of Levetiracetam

Note:


412 SR No 01203501

Item Hydroxyurea capsule 500mg 290,139 Caps

Page No 85 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Hydroxyurea/Hydroxycarbamide BP 500mg capsules.

Each capsule to contain 500mg of Hydroxyurea/Hydroxycarbamide

BP.

Capsules should also conform to dissolution test as for Hydroxyurea

capsules USP

OR

Hydroxyurea capsule USP.

Each capsule to contain 500mg of Hydroxyurea USP.

Note:


413 SR No 00903601

Item Carbachol intraoccularsol.0.01%,1ml 3,537 Vials

Specification Carbachol intraocular solution USP, 0.01%, 1ml dropper bottle

Each dropper bottle to contain sterile solution of 0.01% of Carbachol

in an aqueous medium.

Note:






Item Vancomycin Inj. 1g Vial 34,185 Vials

Specification Vancomycin Hydrochloride for injection USP, 1g in 20ml Vial

Each 20ml vial to contain Vancomycin Hydrochloride USP equivalent

to 1g of

Vancomycin as sterile dry powder for reconstitution with water for

injection

BP/USP, for intravenous use.

OR

Vancomycin Hydrochloride for injection BP, 1g in 20ml Vial

Each 20ml vial to contain Vancomycin Hydrochloride BP equivalent to

1g of

Vancomycin, as sterile dry powder for reconstitution with water for

injection

BP/USP, for intravenous use.

Note:


stored below

25 0'C


Item Bisacodyl tablet 10mg 302,727 Tabs

Specification Bisacodyl tablets BP/USP, 10mg

Each enteric-coated tablet to contain 10mg of Bisacodyl BP/USP

Note:


416 SR No 00202703

Item Captopril Syrup 5mg / ml ,100ml bottle 819 Bots

Page No 86 of 89




NO OF ITEMS 418


ITEM QUANTITY

Specification Captopril oral solution BP 5mg/ml, 100ml bottle

Each 100ml bottle to contain 5mg/ml of captopril BP / USP in a

suitable flavoured and sweetened syrup base

Note:

1. The preparation should be free from sugar.


3. The product should be protected from light


417 SR No 00000403

Item Fentanyl transdermal patches25mcg per hour 1,152 Patchs

Specification Fentanyl Citrate transdermal self adhesive patches 25mcg/h, Each

self adhesive transdermal patch to contain Fentanyl

Citrate in a suitable matrix or reservoir presentation.

The content should be released at a constant rate of 25mcg/h for 72

hours.

Note:

1. This transdermal patch should be stable for minimum of 24


2. Each patch to be labelled accordingly418 SR No 00200102

Item Digoxin Inj. 500 mcg/2ml 1,845 Amps

Specification Digoxin Injection BP 500mcg/2ml

Each 2ml Ampoule to contain 500mcg of Digoxin BP for slow

intravenous injection and intravenous infusion

OR

Digoxin Injection USP 500mcg/2ml

Each 2ml ampoule to contain 500mcg of Digoxin USP for slow

intravenous injection and intravenous infusion

Note:

1. This injection should be stable for a minimum of


2. Should be protected from light

3. Each ampoule should be labelled accordingly

5. Related Tender Number, SR number of the item and description of item.

6. Contact details of the bidder (Contact Person, TP Nos, (Land/mobile), Fax, e-mail)

Your quotation / quotations shall be placed in the relevant tender box; which is placed with the chief Security Officer of Head

Office of the State Pharmaceuticals Corporation prior to closing date and time indicated above. (Any late delivered / submitted

bids will be rejected without accepting)

In addition, the following information also should be indicated in your quotation.

1. Delivery Date

2. Availability of Ex-Stocks (Ex- Stocks are expected to be supplied within two (02) working days after placing the order.

3. Delivery Schedule / date (in case if Ex- Stocks are not available)

4. Shelf Life of the item (Date of Manufacture and Date of Expiry)

Conditions to the Tender

You are requested to indicate the lowest price in Sri Lankan Rupees that could be afforded.

A Certified copy of the National Medicines Regulation Authority (NMRA – Sri Lanka) Registration Certificate, Certificate of

Analysis (COA) should be forwarded along with the quotation.

Page No 87 of 89




NO OF ITEMS 418


ITEM QUANTITY

iv) Certificate of Analysis of the Product

1. The Product should have minimum of 15 months shelf life at the time of delivery at Medical Supplies Division.

2. Description of item, Date of manufacture, Date of expiry, Batch No, Name and address of manufacture should be clearly marked

on the outer covering containing the item and on the outer cover of the carton/box.

3. In case if the supplier / manufacturer is not registered with NMRA – Sri Lanka, please provide following details together

with the bid (Quotation)

i) GMP certificate

ii) Certificate of Pharmaceutical Products

iii) Manufacturer’s information letter

SPC reserves the right to call samples from bidders who have not submitted samples before closing of the tender in cases of

none of the bidders had submitted samples, evaluators are with the opinion of calling samples from bidders who have not

submitted samples and / or the Procurement committee is with the opinion of calling of samples from the bidders who have not

submitted samples will help them to make a cost effective decision.

Note

1. Please indicate the current market whole sale and Retail prices in your quotation (bid)

Tender Samples, with clear indication of the Tender No, shall be handed over to the Administration Department on or before

the closing of tender and acknowledgement of such samples should be attached to the quotation (bid).

2. Your Quotation (bid) shall be submitted in one original and one duplicate, sealed separately and marked as “ORIGINAL”

and “DUPLICATE” respectively. Both envelopes shall be enclosed in one envelop and deposited in the tender box kept with

the Chief Security Officer of Head Office of the State Pharmaceuticals Corporation. (All the envelopes shall be marked with

the relevant SR number/numbers of the item you are quoting)

3. Offers for any other economically viable pack sizes different from the specified pack sizes are acceptable with the prior approval of

Director Medical Supplies Division when necessary.

4. MSD Order List No(will be notified with the Purchase Order, in case if awarded ) , SR No. of Item, SPC Indent No/purchase order

no Description and storage condition of item and Batch No shall be indicated in all Supply Invoices.

5. Storage condition of the items should be clearly indicated in the inner most and outer most carton labels.

CONDITIONS OF SUPPLY

7. Delivery of the items is to be made to Medical Supplies Division warehouse free of charge.

8. Withdrawal from use of Item due to quality failure.

a) In case of batch withdrawal due to quality failure, the supplier/ manufacturer shall reimburse the value of entire batch

quantity supplied.

6. Cold chain monitors should be included for each cartons and the cold chain should be maintained according to the manufacturer's

instructions during storage, transport and delivery.

Page No 88 of 89




NO OF ITEMS 418


ITEM QUANTITY

13. IN CASE OF AWARD, DELIVERY OF SPC MAIN ORDER(S) WILL BE CONSIDERED PRIOR TO RELEASEING THE INDENT / PURCHASE

ORDER FOR THE LOCAL SUPPLY

9. Standard- any other pharmaceutical standard accepted by cosmetics, devices and drugs regulatory authority in Sri-Lanka for

registration of pharmaceutical item also acceptable.

10. In the event that item is awarded to an unregistered bidder, the NOL (Waiver of Registration) issued by NMRA should be submitted

when item is delivered. If not, payment will not be released for the delivered item. (In case of applying for NOL (Waiver of

Registration), relevant fee due to NMRA shall be borne by the supplier)

11. In the event of failing to supply the item within the delivery schedule given the Purchase order the item will not be accepted by

MSD. However, if the item is still required by Medical Supplies Division and decides to accept the same , a penalty of 0.1% of the total

value per day up to 7 days(total of 0.7% for 1st 7days of late delivery), 0.3%per total value per day from 8th to 14th (another 2.1% for 7

days from 8th to 14th day of late delivery),0.5% per total value per day from 15th to 21st day (another 3.5% for the period from 15th

to 21st day of late delivery) for the lapsed period will be deducted from your payment as liquidated damage.

In case of an item delivered after 3 weeks, if the item is still required MSD reserves the right to accept maximum penalty of 10% of the

total value will be imposed.

12. In addition to the condition given herein any other relevant condition as per the tender document issued by SPC are also

applicable.

b) In case of product withdrawal due to quality failure, the supplier/ manufacturer shall reimburse the value of entire product

quantity supplied.

c) In the event of either a) or b) above the supplier/manufacturer shall be surcharged additional 25% of the total value

concerned as administrative cost.

Page No 89 of 89

Documents

STATE PHARMACEUTICALS CORPORATION OF SRI ......2020/04/15 · Specification Diclofenac Sodium suppository 25mg Each suppository to contain 25mg of Diclofenac Sodium BP/USP in a suitable